<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-gb" lang="en-gb">

<head>
	<script type="text/javascript">
var siteurl='/';
var tmplurl='/templates/ja_teline_iv/';
var isRTL = false;
</script>

  <base href="http://hivandhepatitis.com/hep_b/news/111403_a.html" />
  <meta http-equiv="content-type" content="text/html; charset=utf-8" />
  <meta name="robots" content="index, follow" />
  <meta name="keywords" content="design,roses,bread,development" />
  <meta name="rights" content="" />
  <meta name="language" content="en-GB" />
  <meta name="description" content=" Web Design and Development by Bread and Roses Web Design " />
  <meta name="generator" content="Joomla! 1.6 - Open Source Content Management" />
  <title>HOME | www.hivandhepatitis.com</title>
  <link href="http://www.hivandhepatitis.com/?id=" rel="canonical"  />
  <link rel="stylesheet" href="/templates/system/css/system.css" type="text/css" />
  <link rel="stylesheet" href="/templates/system/css/general.css" type="text/css" />
  <link rel="stylesheet" href="/plugins/content/plg_jathumbnail/style.css" type="text/css" />
  <link rel="stylesheet" href="/modules/mod_janews_featured/assets/css/style.css" type="text/css" />
  <link rel="stylesheet" href="/modules/mod_janews_featured/tmpl/default/style.css" type="text/css" />
  <link rel="stylesheet" href="/modules/mod_janewspro/assets/css/style.css" type="text/css" />
  <link rel="stylesheet" href="/modules/mod_janewspro/tmpl/default/style.css" type="text/css" />
  <link rel="stylesheet" href="/modules/mod_jatwitter/assets/style.css" type="text/css" />
  <link rel="stylesheet" href="/plugins/system/jat3/jat3/base-themes/default/css/typo.css" type="text/css" />
  <link rel="stylesheet" href="/plugins/system/jat3/jat3/base-themes/default/css/addons.css" type="text/css" />
  <link rel="stylesheet" href="/plugins/system/jat3/jat3/base-themes/default/css/layout.css" type="text/css" />
  <link rel="stylesheet" href="/plugins/system/jat3/jat3/base-themes/default/css/template.css" type="text/css" />
  <link rel="stylesheet" href="/plugins/system/jat3/jat3/base-themes/default/css/usertools.css" type="text/css" />
  <link rel="stylesheet" href="/plugins/system/jat3/jat3/base-themes/default/css/css3.css" type="text/css" />
  <link rel="stylesheet" href="/plugins/system/jat3/jat3/base-themes/default/css/menu/mega.css" type="text/css" />
  <link rel="stylesheet" href="/templates/ja_teline_iv/css/typo.css" type="text/css" />
  <link rel="stylesheet" href="/templates/ja_teline_iv/css/layout.css" type="text/css" />
  <link rel="stylesheet" href="/templates/ja_teline_iv/css/template.css" type="text/css" />
  <link rel="stylesheet" href="/templates/ja_teline_iv/css/css3.css" type="text/css" />
  <link rel="stylesheet" href="/templates/ja_teline_iv/css/menu/mega.css" type="text/css" />
  <link rel="stylesheet" href="/templates/ja_teline_iv/html/mod_janews_featured/default/style.css" type="text/css" />
  <link rel="stylesheet" href="/templates/ja_teline_iv/html/mod_janewspro/default/style.css" type="text/css" />
  <style type="text/css">

.blank1BM{
margin-top:0px;
margin-bottom:0px;
margin-left:0px;
overflow:hidden;
padding-left:0px; 
padding-right:0px;
padding-top:0px;
padding-bottom:0px;
width:100%;
background:#ffffff;}
  </style>
  <script type="text/javascript" src="/media/system/js/core.js"></script>
  <script type="text/javascript" src="/media/system/js/mootools-core.js"></script>
  <script type="text/javascript" src="/media/system/js/mootools-more.js"></script>
  <script type="text/javascript" src="/templates/ja_teline_iv/js/mega.more.js"></script>
  <script type="text/javascript" src="/plugins/system/jat3/jat3/base-themes/default/js/core.js"></script>
  <script type="text/javascript" src="/plugins/system/jat3/jat3/base-themes/default/js/menu/mega.js"></script>
  <script type="text/javascript" src="/media/system/js/caption.js"></script>
  <script type="text/javascript" src="/modules/mod_janews_featured/tmpl/default/script.js"></script>
  <script type="text/javascript" src="/modules/mod_janewspro/assets/js/script.js"></script>
  <script type="text/javascript">

		window.addEvent('domready', function() {
			$$('.hasTip').each(function(el) {
				var title = el.get('title');
				if (title) {
					var parts = title.split('::', 2);
					el.store('tip:title', parts[0]);
					el.store('tip:text', parts[1]);
				}
			});
			var JTooltips = new Tips($$('.hasTip'), { maxTitleChars: 50, fixed: false});
		});
  </script>
  <meta property="og:title" content="HOME | www.hivandhepatitis.com"/>
  <meta property="og:type" content="article"/>
  <meta property="og:url" content="http://hivandhepatitis.com/hep_b/news/111403_a.html"/>
  <meta property="og:site_name" content="HIVandHepatitis.com"/>
  <meta property="fb:admins" content="0"/>
  <meta property="og:image" content="http://www.hivandhepatitis.com/images/icons/logo-tiny.jpg"/>
  <script type="text/javascript">

  var _gaq = _gaq || [];
  _gaq.push(['_setAccount', 'UA-24945328-1']);
  _gaq.push(['_trackPageview']);

  (function() {
    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
  })();

</script>




<link href="/templates/ja_teline_iv/images/favicon.ico" rel="shortcut icon" type="image/x-icon" />


<!--[if IE 7.0]>
<style>
.clearfix { display: inline-block; } /* IE7xhtml*/
</style>
<![endif]-->
		
	<style type="text/css">


/*dynamic css*/
	body.bd .main {width: 980px;}
	body.bd #ja-wrapper {min-width: 980px;}
</style></head>

<body id="bd" class="bd  fs3 com_content">
<div id="ja-wrapper">
	<a name="Top" id="Top"></a>
	
					<div id="ja-header" class="wrap ">		
				
			
					<div class="main clearfix">
		
				
		<h1 class="logo">
		<a href="/index.php" title="www.hivandhepatitis.com"><span>www.hivandhepatitis.com</span></a>
	</h1>
		
	<div class="ja-header-r">
		
<form action="index.php"  method="post" class="search" style="text-align:center;">
	<!--<label for="mod_search_searchword">
		<strong>search: </strong>
	</label>-->
	<input name="searchword" id="mod_search_searchword" class="inputbox" type="text" size="25" value="" /><input type="submit" value="Search" class="button"/>	<input type="hidden" name="option" value="com_search" />
	<input type="hidden" name="task"   value="search" />
</form>

	</div>		 
		
				
					</div>
		
			
				</div>		
				<div id="ja-topmegamenu" class="wrap ">		
				
			
					<div class="main clearfix">
		
				
		<div id="ja-topnav" class="clearfix">
	<div class="ja-megamenu clearfix" id="ja-topmega">
<ul class="megamenu level0"><li  class="mega first haschild nav-feeds"><a href="#"  class="mega first haschild nav-feeds" id="menu605" title="RSS"><span class="menu-title">RSS</span></a><div class="childcontent cols1 ">
<div class="childcontent-inner-wrap">
<div class="childcontent-inner clearfix" style="width: 290px;">	<div class="ja-moduletable moduletable  clearfix" id="Mod37">
						<h3><span>Syndicate Feeds</span></h3>
				<div class="ja-box-ct clearfix">
				</div>
    </div>
	</div>
</div></div></li><li  class="mega haschild nav-social"><a href="http://twitter.com/#!/HIVandHepatitis" onclick="window.open(this.href,'targetWindow','toolbar=no,location=no,status=no,menubar=no,scrollbars=yes,resizable=yes,');return false;"  class="mega haschild nav-social" id="menu604" title="Twitter"><span class="menu-title">Twitter</span></a><div class="childcontent cols1 ">
<div class="childcontent-inner-wrap">
<div class="childcontent-inner clearfix" style="width: 275px;">	<div class="ja-moduletable moduletable  clearfix" id="Mod136">
						<div class="ja-box-ct clearfix">
		<div class="ja-twitter">
		
	<!-- ACCOUNT INFOMATION -->
		<!-- // ACCOUNT INFOMATION -->
	
	<!-- LISTING TWEETS -->
		
	<!-- //LISTING TWEETS -->
	
	<!-- LISTING FRIENDS -->
		<!-- //LISTING FRIENDS -->
		<center>
	
				<center>
				<script src="http://platform.twitter.com/anywhere.js?id=wMOXZUmWegMztLtrPB9I1Q&v=1" type="text/javascript"></script>
				  <div id="anywhere-block-follow-button"></div>
				  <script type="text/javascript">
				  twttr.anywhere(function (twitter) {
						  twitter("#anywhere-block-follow-button").followButton("HIVandHepatitis");
					  });
				  </script>
				</center>
					</center>
	</div>		</div>
    </div>
	</div>
</div></div></li><li  class="mega nav-youtube"><a href="http://www.youtube.com/user/HIVandHepatitis" onclick="window.open(this.href,'targetWindow','toolbar=no,location=no,status=no,menubar=no,scrollbars=yes,resizable=yes,');return false;"  class="mega nav-youtube" id="menu838" title="Youtube"><span class="menu-title">Youtube</span></a></li><li  class="mega nav-blog"><a href="http://www.facebook.com/pages/HIVandHepatitiscom/101717350662" onclick="window.open(this.href,'targetWindow','toolbar=no,location=no,status=no,menubar=no,scrollbars=yes,resizable=yes,');return false;"  class="mega nav-blog" id="menu831" title="Facebook"><span class="menu-title">Facebook</span></a></li><li  class="mega last nav-contactus"><a href="/contact-us-menu"  class="mega last nav-contactus" id="menu839" title="Contact Us"><span class="menu-title">Contact Us</span></a></li></ul>
</div>			<script type="text/javascript">
			var megamenu = new jaMegaMenuMoo ('ja-topmega', {
				'bgopacity': 0, 
				'delayHide': 300, 
				'slide': 0, 
				'fading': 0,
				'direction':'down',
				'action':'mouseover',
				'tips': false,
				'duration': 300,
				'hidestyle': 'fastwhenshow'
			});			
			</script>
			</div>
		 
		
				
					</div>
		
			
				</div>				<div id="ja-mainnav" class="wrap ">		
				
			
					<div class="main clearfix">
		
				
		<div class="ja-megamenu clearfix" id="ja-megamenu">
<ul class="megamenu level0"><li  class="mega first haschild active home"><a href="http://www.hivandhepatitis.com/"  class="mega first haschild active home" id="menu490" title="Home"><span class="menu-title">Home</span></a><div class="childcontent cols3 ">
<div class="childcontent-inner-wrap">
<div class="childcontent-inner clearfix" style="width: 690px;"><div class="megacol column1 first" style="width: 200px;"><ul class="megamenu level1"><li  class="mega first group"><div class="group"><div class="group-title"><a href="/home1706522085/about-us"  class="mega first group" id="menu491" title="About Us"><span class="menu-title">About Us</span></a></div><div class="group-content"><ul class="megamenu level1"><li  class="mega first"><a href="/home1706522085/about-us/our-team"  class="mega first" id="menu647" title="Our Team"><span class="menu-title">Our Team</span></a></li><li  class="mega"><a href="/home1706522085/about-us/fine-print"  class="mega" id="menu820" title="The Fine Print"><span class="menu-title">The Fine Print</span></a></li><li  class="mega last"><a href="/home1706522085/about-us/overview"  class="mega last" id="menu493" title="Overview"><span class="menu-title">Overview</span></a></li></ul></div></div></li></ul></div><div class="megacol column2" style="width: 200px;"><ul class="megamenu level1"><li  class="mega first group"><div class="group"><div class="group-title"><a href="/home1706522085/get-in-touch"  class="mega first group" id="menu501" title="Get in touch"><span class="menu-title">Get in touch</span></a></div><div class="group-content"><ul class="megamenu level1"><li  class="mega first"><a href="/home1706522085/get-in-touch/contact-us" target="_blank"  class="mega first" id="menu503" title="Contact Us"><span class="menu-title">Contact Us</span></a></li><li  class="mega last"><a href="http://www.facebook.com/pages/HIVandHepatitiscom/101717350662" target="_blank"  class="mega last" id="menu504" title="Find Us on Facebook"><span class="menu-title">Find Us on Facebook</span></a></li></ul></div></div></li></ul></div><div class="megacol column3 last" style="width: 290px;"><ul class="megamenu level1"><li  class="mega first group"><div class="group"><div class="group-title"><a href="#"  class="mega first group" id="menu512" title="Content"><span class="menu-title">Content</span></a></div><div class="group-content"><ul class="megamenu level1"><li  class="mega first"><a href="/home1706522085/content/past-conferences-menu"  class="mega first" id="menu997" title="Past Conferences"><span class="menu-title">Past Conferences</span></a></li><li  class="mega"><a href="/home1706522085/content/conference-coverage"  class="mega" id="menu506" title="Conference Coverage"><span class="menu-title">Conference Coverage</span></a></li><li  class="mega last"><a href="/home1706522085/content/library-of-cme-programs"  class="mega last" id="menu507" title="Library of CME Programs"><span class="menu-title">Library of CME Programs</span></a></li></ul></div></div></li></ul></div></div>
</div></div></li><li  class="mega haschild"><a href="/hiv-aids"  class="mega haschild" id="menu514" title="HIV/AIDS"><span class="menu-title">HIV/AIDS</span></a><div class="childcontent cols1 ">
<div class="childcontent-inner-wrap">
<div class="childcontent-inner clearfix" style="width: 200px;"><div class="megacol column1 first" style="width: 200px;"><ul class="megamenu level1"><li  class="mega first group"><div class="group"><div class="group-title"><a href="#"  class="mega first group" id="menu515" title="HIV/AIDS Topics"><span class="menu-title">HIV/AIDS Topics</span></a></div><div class="group-content"><ul class="megamenu level1"><li  class="mega first"><a href="/hiv-aids/hiv-aids-topics/hiv-prevention"  class="mega first" id="menu822" title="HIV Prevention"><span class="menu-title">HIV Prevention</span></a></li><li  class="mega"><a href="/hiv-aids/hiv-aids-topics/hiv-disease-progression"  class="mega" id="menu671" title="HIV Disease Progression"><span class="menu-title">HIV Disease Progression</span></a></li><li  class="mega"><a href="/hiv-aids/hiv-aids-topics/hiv-populations"  class="mega" id="menu836" title="HIV Populations"><span class="menu-title">HIV Populations</span></a></li><li  class="mega"><a href="/hiv-aids/hiv-aids-topics/hiv-treatment"  class="mega" id="menu516" title="HIV Treatment"><span class="menu-title">HIV Treatment</span></a></li><li  class="mega"><a href="/hiv-aids/hiv-aids-topics/hiv-testing-diagnosis"  class="mega" id="menu519" title="HIV Testing &amp; Diagnosis"><span class="menu-title">HIV Testing &amp; Diagnosis</span></a></li><li  class="mega last"><a href="/hiv-aids/hiv-aids-topics/hiv-related-conditions"  class="mega last" id="menu521" title="HIV-Related Conditions"><span class="menu-title">HIV-Related Conditions</span></a></li></ul></div></div></li></ul></div></div>
</div></div></li><li  class="mega haschild"><a href="/hepatitis-b"  class="mega haschild" id="menu524" title="Hepatitis B"><span class="menu-title">Hepatitis B</span></a><div class="childcontent cols1 ">
<div class="childcontent-inner-wrap">
<div class="childcontent-inner clearfix" style="width: 200px;"><div class="megacol column1 first" style="width: 200px;"><ul class="megamenu level1"><li  class="mega first group"><div class="group"><div class="group-title"><a href="#"  class="mega first group" id="menu525" title="Hepatitis B Topics"><span class="menu-title">Hepatitis B Topics</span></a></div><div class="group-content"><ul class="megamenu level1"><li  class="mega first"><a href="/hepatitis-b/hepatitis-b-topics/hbv-treatment"  class="mega first" id="menu691" title="HBV Treatment"><span class="menu-title">HBV Treatment</span></a></li><li  class="mega"><a href="/hepatitis-b/hepatitis-b-topics/hbv-disease-progression"  class="mega" id="menu850" title="HBV Disease Progression"><span class="menu-title">HBV Disease Progression</span></a></li><li  class="mega"><a href="/hepatitis-b/hepatitis-b-topics/hbv-populations"  class="mega" id="menu692" title="HBV Populations"><span class="menu-title">HBV Populations</span></a></li><li  class="mega"><a href="/hepatitis-b/hepatitis-b-topics/hbv-prevention"  class="mega" id="menu526" title="HBV Prevention"><span class="menu-title">HBV Prevention</span></a></li><li  class="mega last"><a href="/hepatitis-b/hepatitis-b-topics/hbv-testing-diagnosis"  class="mega last" id="menu531" title="HBV Testing &amp; Diagnosis"><span class="menu-title">HBV Testing &amp; Diagnosis</span></a></li></ul></div></div></li></ul></div></div>
</div></div></li><li  class="mega"><a href="/hepatitis-c"  class="mega" id="menu534" title="Hepatitis C"><span class="menu-title">Hepatitis C</span></a></li><li  class="mega haschild"><a href="/hiv-hep-coinfection"  class="mega haschild" id="menu541" title="HIV/Hepatitis Coinfection"><span class="menu-title">HIV/Hepatitis Coinfection</span></a><div class="childcontent cols2 ">
<div class="childcontent-inner-wrap">
<div class="childcontent-inner clearfix" style="width: 400px;"><div class="megacol column1 first" style="width: 200px;"><ul class="megamenu level1"><li  class="mega first"><a href="/hiv-hep-coinfection/hiv-hbv-coinfection"  class="mega first" id="menu1000" title="HIV/HBV Coinfection"><span class="menu-title">HIV/HBV Coinfection</span></a></li></ul></div><div class="megacol column2 last" style="width: 200px;"><ul class="megamenu level1"><li  class="mega first"><a href="/hiv-hep-coinfection/hiv-hcv-coinfection"  class="mega first" id="menu1002" title="HIV/HCV Coinfection"><span class="menu-title">HIV/HCV Coinfection</span></a></li></ul></div></div>
</div></div></li><li  class="mega last haschild"><a href="/other-health-news"  class="mega last haschild" id="menu551" title="Other Health News"><span class="menu-title">Other Health News</span></a><div class="childcontent cols1 ">
<div class="childcontent-inner-wrap">
<div class="childcontent-inner clearfix" style="width: 200px;"><div class="megacol column1 first" style="width: 200px;"><ul class="megamenu level1"><li  class="mega first group"><div class="group"><div class="group-title"><a href="#"  class="mega first group" id="menu552" title="Other Health News Topics"><span class="menu-title">Other Health News Topics</span></a></div><div class="group-content"><ul class="megamenu level1"><li  class="mega first"><a href="/other-health-news/other-health-news-topics/influenza-blog"  class="mega first" id="menu970" title="Influenza"><span class="menu-title">Influenza</span></a></li><li  class="mega"><a href="/other-health-news/other-health-news-topics/tuberculosis"  class="mega" id="menu1005" title="Tuberculosis"><span class="menu-title">Tuberculosis</span></a></li><li  class="mega"><a href="/other-health-news/other-health-news-topics/hpv"  class="mega" id="menu554" title="Human Papillomavirus (HPV)"><span class="menu-title">Human Papillomavirus (HPV)</span></a></li><li  class="mega"><a href="/other-health-news/other-health-news-topics/other-stds"  class="mega" id="menu556" title="Other STDs"><span class="menu-title">Other STDs</span></a></li><li  class="mega last"><a href="/other-health-news/other-health-news-topics/xmrv-2"  class="mega last" id="menu558" title="XMRV, MLV &amp; Other Retroviruses"><span class="menu-title">XMRV, MLV &amp; Other Retroviruses</span></a></li></ul></div></div></li></ul></div></div>
</div></div></li></ul>
</div>			<script type="text/javascript">
			var megamenu = new jaMegaMenuMoo ('ja-megamenu', {
				'bgopacity': 0, 
				'delayHide': 300, 
				'slide': 0, 
				'fading': 0,
				'direction':'down',
				'action':'mouseover',
				'tips': false,
				'duration': 300,
				'hidestyle': 'fastwhenshow'
			});			
			</script>
			<!-- jdoc:include type="menu" level="0" / -->

<ul class="no-display">
    <li><a href="#ja-content" title="Skip to content">Skip to content</a></li>
</ul>		 
		
				
					</div>
		
			
				</div>		
								<div id="ja-topbar" class="wrap ">		
				
			
					<div class="main clearfix">
		
				
		<!--<p class="ja-day clearfix">
	  <span class="day">Tue</span><span class="month">11</span><span class="date">10</span><span class="year">2020</span>	</p>
	 
	<p class="ja-updatetime"><span>Last update</span><em>08:00:00 AM GMT</em></p>
	
		
		<div id="ja-search">
		<div class="blank1BM" ><br/><br/></div>
	</div>
	-->		 
		
				
					</div>
		
			
				</div>		
				
	<!-- MAIN CONTAINER -->
	<div id="ja-container" class="wrap ja-r2">
					
			
					<div class="main">
		
				
		 
			<div class="main-inner1 clearfix">
				<div id="ja-mainbody" style="width:66%">
			<!-- CONTENT -->
			<div id="ja-main" style="width:100%">
			<div class="inner clearfix">
				
				
<dl id="system-message">
<dt class="error">Error</dt>
<dd class="error message">
	<ul>
		<li>Article not found</li>
	</ul>
</dd>
</dl>
								<div id="ja-content-mass-top" class="ja-mass ja-mass-top clearfix">
							
		<div class="ja-blocktab">


<div class="ja-blocktab-content clearfix">	
	<!--  -->

<div id="ja-zinfp-wrap-160" class="ja-zinfp-wrap default">
<div id="ja-zinfp-160" class="ja-zinfp clearfix">

	<div class="ja-zinfp-main-wrap">
	<div class="ja-zinfp-main clearfix">
		<div class="ja-zinfp-featured-wrap column">
		<div class="ja-zinfp-featured-border">
		<div class="ja-zinfp-featured clearfix">
					<div class="ja-zincontent-wrap active show">
			<div class="ja-zincontent clearfix">
				
				<div class="ja-zincontent-img clearfix" style="float:0">
				<img class="0" src="/images/resized/images/special-occasion/2017-beach-dreamstime_330_228.jpg" alt="Top 10 HIV and Hepatitis Stories of 2017"  />				</div>
				
				<h2 class="ja-zintitle">
					<a href="/hiv-aids/hiv-aids-topics/hiv-treatment/6165-top-10-hiv-and-hepatitis-stories-of-2017" title="Top 10 HIV and Hepatitis Stories of 2017">
						Top 10 HIV and Hepatitis Stories of 2017					</a>
				</h2>
				
				<p>
For our last issue, HIVandHepatitis.com reviews some the year&#39;s major HIV, viral hepatitis, and related news highlights. As we enter 2018, antiretroviral treatment for HIV is about as good as it can get, use of PrEP for HIV prevention is expanding rapidly, and most people can be cured of hepatitis C with 2 or 3 months of well-tolerated therapy. But these advances are still not reaching everyone who needs them. The search for a functional cure for HIV, better treatments for hepatitis B, and m...
</p>
				
								<p class="readmore">
					<a href="/hiv-aids/hiv-aids-topics/hiv-treatment/6165-top-10-hiv-and-hepatitis-stories-of-2017" class="readon" title="READ MORE..."><span>READ MORE...</span></a>
				</p>
							</div>
			</div>
			
												<div class="ja-zincontent-wrap hide">
			<div class="ja-zincontent clearfix">
				
				<div class="ja-zincontent-img clearfix" style="float:0">
				<img class="0" src="/images/resized/images/conf-photos/Other/stage1-img_3073-rect700_330_228.jpg" alt="HIV Cure Summit Hears About New Remission Case"  />				</div>
				
				<h2 class="ja-zintitle">
					<a href="/hiv-treatment/hiv-cure/6163-hiv-cure-summit-hears-about-new-remission-case" title="HIV Cure Summit Hears About New Remission Case">
						HIV Cure Summit Hears About New Remission Case					</a>
				</h2>
				
				<p>
	The past year brought no major breakthroughs in the search for an HIV cure, but a growing understanding of how the virus hides in the body bring us closer to strategies for long-term remission, researchers and advocates said at the 2017 HIV Cure Summit in San Francisco.</p>
<p>
	</p>				
								<p class="readmore">
					<a href="/hiv-treatment/hiv-cure/6163-hiv-cure-summit-hears-about-new-remission-case" class="readon" title="READ MORE..."><span>READ MORE...</span></a>
				</p>
							</div>
			</div>
			
												<div class="ja-zincontent-wrap hide">
			<div class="ja-zincontent clearfix">
				
				<div class="ja-zincontent-img clearfix" style="float:0">
				<img class="0" src="/images/resized/images/conf-logos-banners/aasld2017-hcv-rect550_330_228.jpg" alt="Coverage of the 2017 AASLD Liver Meeting"  />				</div>
				
				<h2 class="ja-zintitle">
					<a href="/hepatitis-b/hepatitis-b-topics/hbv-treatment/6161-coverage-of-the-2017-aasld-liver-meeting2" title="Coverage of the 2017 AASLD Liver Meeting">
						Coverage of the 2017 AASLD Liver Meeting					</a>
				</h2>
				
				<p>
HIVandHepatitis.com coverage of the 2017 American Association for the Study of Liver Diseases (AASLD)&nbsp;Liver Meeting in Washington, DC, October 20-24, 2017.
</p>
<p>
Conference highlights include direct-acting antiviral therapy for difficult-to-treat people with hepatitis C, novel hepatitis B agents, complications of viral hepatitis, and NAFLD/NASH.
</p>
<p>
<strong>
<a href="http://www.hivandhepatitis.com/hepatitis-b/6160-coverage-of-the-2017-aasld-liver-meeting-listing">
Full coverage listing by topic
</a>
</strong>
</p>
<p>
<a href="https://www.aasld.org/events-professional-development/liver-meeting">
<strong>
The Liver Meeting website
</strong>
</a>
</p>
<p>
11/30/17
</p>
				
								<p class="readmore">
					<a href="/hepatitis-b/hepatitis-b-topics/hbv-treatment/6161-coverage-of-the-2017-aasld-liver-meeting2" class="readon" title="READ MORE..."><span>READ MORE...</span></a>
				</p>
							</div>
			</div>
			
												<div class="ja-zincontent-wrap hide">
			<div class="ja-zincontent clearfix">
				
				<div class="ja-zincontent-img clearfix" style="float:0">
				<img class="0" src="/images/resized/images/conf-logos-banners/ias2017-eiffel-rect500_330_228.jpg" alt="Coverage of the 2017 IAS Conference on HIV Science"  />				</div>
				
				<h2 class="ja-zintitle">
					<a href="/hiv-aids/hiv-aids-topics/hiv-treatment/6123-coverage-of-the-2017-ias-conference-on-hiv-science" title="Coverage of the 2017 IAS Conference on HIV Science">
						Coverage of the 2017 IAS Conference on HIV Science					</a>
				</h2>
				
				<p>
	HIVandHepatitis.com coverage of the 9th International AIDS Society Conference on HIV Science, July 23-26, 2017, in Paris.</p>
<p>
	<a href="http://hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/6124-coverage-of-the-2017-ias-conference-on-hiv-science-listing"><strong>Full&nbsp;</strong><strong>coverage listing by topic</strong></a></p>
<p>
	<a href="https://www.ias2017.org/"><strong>IAS 2017 website</strong></a></p>
<p>
	7/31/17</p>
<p>
	</p>				
								<p class="readmore">
					<a href="/hiv-aids/hiv-aids-topics/hiv-treatment/6123-coverage-of-the-2017-ias-conference-on-hiv-science" class="readon" title="READ MORE..."><span>READ MORE...</span></a>
				</p>
							</div>
			</div>
			
												<div class="ja-zincontent-wrap hide">
			<div class="ja-zincontent clearfix">
				
				<div class="ja-zincontent-img clearfix" style="float:0">
				<img class="0" src="/images/resized/images/conf-logos-banners/easl2017-keukenhof3b_330_228.jpg" alt="Coverage of the 2017 EASL International Liver Conference"  />				</div>
				
				<h2 class="ja-zintitle">
					<a href="/hepatitis-b/6080-coverage-of-the-2017-easl-international-liver-conference" title="Coverage of the 2017 EASL International Liver Conference">
						Coverage of the 2017 EASL International Liver Conference					</a>
				</h2>
				
				<p>
HIVandHepatitis.com coverage of the 2017 International Liver Congress, annual meeting of the European Society for the Study of the Liver (EASL), April 19-23, 2017, in Amsterdam
</p>
<p>
<a href="http://www.hivandhepatitis.com/hepatitis-b/6077-coverage-of-the-2017-easl-international-liver-congress-listing">
<strong>
Full&nbsp;
</strong>
<strong>
coverage listing by topic
</strong>
</a>
</p>
<p>
<a href="https://ilc-congress.eu/">
<strong>
International Liver Congress website
</strong>
</a>
</p>
<p>
4/30/17
</p>
				
								<p class="readmore">
					<a href="/hepatitis-b/6080-coverage-of-the-2017-easl-international-liver-conference" class="readon" title="READ MORE..."><span>READ MORE...</span></a>
				</p>
							</div>
			</div>
			
												<div class="ja-zincontent-wrap hide">
			<div class="ja-zincontent clearfix">
				
				<div class="ja-zincontent-img clearfix" style="float:0">
				<img class="0" src="/images/resized/images/conf-logos-banners/croi2017-chihuly2-img_1662-rect700_330_228.jpg" alt="Coverage of the 2017 Conference on Retroviruses and Opportunistic Infections"  />				</div>
				
				<h2 class="ja-zintitle">
					<a href="/hiv-aids/hiv-aids-topics/hiv-treatment/6042-coverage-of-the-2017-conference-on-retroviruses-and-opportunistic-infections" title="Coverage of the 2017 Conference on Retroviruses and Opportunistic Infections">
						Coverage of the 2017 Conference on Retroviruses and Opportunistic Infections					</a>
				</h2>
				
				<p>
	HIVandHepatitis.com coverage of the 2017 Conference on Retroviruses and Opportunistic infections (CROI 2017), February 13-16, 2017, in Seattle.</p>
<p>
	<strong><a href="http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/6075-coverage-of-the-2017-conference-on-retroviruses-and-opportunistic-infections">Full coverage listing by topic</a></strong></p>
<p>
	<a href="http://www.croiconference.org/"><strong>CROI website</strong></a></p>
<p>
	4/16/17</p>
<p>
	</p>				
								<p class="readmore">
					<a href="/hiv-aids/hiv-aids-topics/hiv-treatment/6042-coverage-of-the-2017-conference-on-retroviruses-and-opportunistic-infections" class="readon" title="READ MORE..."><span>READ MORE...</span></a>
				</p>
							</div>
			</div>
			
					</div>
					<div class="ja-zinfp-links-actions">
				<span class="box-counter"><span class="counter">1</span> of 6</span>
				<a href="javascript:void(0)" class="ja-zinfp-links-actions-next next">
					<span>Next</span>					
				</a>
				<a href="javascript:void(0)" class="ja-zinfp-links-actions-prev prev">
					<span>Prev</span>
				</a>
				<span class="next"><img src="/modules/mod_janews_fp/tmpl/default/loading.gif" alt="Loading"/></span>
			</div>
					</div>
		</div>

		<div class="ja-zinfp-normal-wrap column">
		<div class="ja-zinfp-normal clearfix">
										
			<div class="ja-zincontent-wrap">
				<div class="ja-zincontent clearfix " >
				
					<div class="ja-zincontent-img" style="float:0">
					<img class="0" src="/images/resized/images/handh-logos/handh-hbv-sq-300_60_60.jpg" alt="A Message To Our Readers"  />					</div>

					<h4 class="ja-zintitle">
						<a href="/hiv-aids/hiv-aids-topics/hiv-treatment/6164-a-message-to-our-readers" title="A Message To Our Readers">
							A Message To Our Readers						</a>
					</h4>
					<div class="ja-zinintro">
											</div>

				</div>
			</div>
								
			<div class="ja-zincontent-wrap">
				<div class="ja-zincontent clearfix " >
				
					<div class="ja-zincontent-img" style="float:0">
					<img class="0" src="/images/resized/images/miscell-images/insite-vancouver-laurathomas-rect750_60_60.jpg" alt="California Supervised Injection Bill Stalls, but San Francisco Moves Forward"  />					</div>

					<h4 class="ja-zintitle">
						<a href="/other-health-news/655-drug-use-drug-use/6166-california-supervised-injection-bill-stalls-but-san-francisco-moves-forward1" title="California Supervised Injection Bill Stalls, but San Francisco Moves Forward">
							California Supervised Injection Bill Stalls, but San Francisco Moves Forward						</a>
					</h4>
					<div class="ja-zinintro">
											</div>

				</div>
			</div>
								
			<div class="ja-zincontent-wrap">
				<div class="ja-zincontent clearfix " >
				
					<div class="ja-zincontent-img" style="float:0">
					<img class="0" src="/images/resized/images/govt-ngo-logos/gettingtozero-sf-lg-sq550_60_60.jpg" alt="San Francisco Getting to Zero Update Hears U=U Message"  />					</div>

					<h4 class="ja-zintitle">
						<a href="/hiv-prevention/hiv-test-treat/6162-san-francisco-getting-to-zero-update-hears-uu-message" title="San Francisco Getting to Zero Update Hears U=U Message">
							San Francisco Getting to Zero Update Hears U=U Message						</a>
					</h4>
					<div class="ja-zinintro">
											</div>

				</div>
			</div>
								
			<div class="ja-zincontent-wrap">
				<div class="ja-zincontent clearfix " >
				
					<div class="ja-zincontent-img" style="float:0">
					<img class="0" src="/images/resized/images/places/london-parliament-img_7342-sq500_60_60.jpg" alt="EACS 2017: How a London Clinic Reduced New HIV Infections by 90%"  />					</div>

					<h4 class="ja-zintitle">
						<a href="/hiv-treatment/hiv-cure/6168-eacs-2017-how-a-london-clinic-reduced-new-hiv-infections-by-90" title="EACS 2017: How a London Clinic Reduced New HIV Infections by 90%">
							EACS 2017: How a London Clinic Reduced New HIV Infections by 90%						</a>
					</h4>
					<div class="ja-zinintro">
											</div>

				</div>
			</div>
								
			<div class="ja-zincontent-wrap">
				<div class="ja-zincontent clearfix " >
				
					<div class="ja-zincontent-img" style="float:0">
					<img class="0" src="/images/resized/images/viruses-Kightly/virus-hiv-group-sq-300_60_60.jpg" alt="EACS 2017: European Cure Review Concentrates on HIV Therapeutic Vaccines"  />					</div>

					<h4 class="ja-zintitle">
						<a href="/hiv-treatment/hiv-cure/6167-eacs-2017-european-cure-review-concentrates-on-hiv-therapeutic-vaccines" title="EACS 2017: European Cure Review Concentrates on HIV Therapeutic Vaccines">
							EACS 2017: European Cure Review Concentrates on HIV Therapeutic Vaccines						</a>
					</h4>
					<div class="ja-zinintro">
											</div>

				</div>
			</div>
								
			<div class="ja-zincontent-wrap">
				<div class="ja-zincontent clearfix " >
				
					<div class="ja-zincontent-img" style="float:0">
					<img class="0" src="/images/resized/images/conf-logos-banners/eacs2017-stripes-sq350_60_60.jpg" alt="EACS 2017: Test-and-Treat Reduces HCV Among Gay Men in Swiss HIV Cohort"  />					</div>

					<h4 class="ja-zintitle">
						<a href="/hcv-prevention/hcv-sexual-transmission/6170-eacs-2017-hepatitis-c-test-and-treat-program-reduces-hcv-by-two-thirds-among-men-who-have-sex-with-men-in-swiss-hiv-cohort" title="EACS 2017: Test-and-Treat Reduces HCV Among Gay Men in Swiss HIV Cohort">
							EACS 2017: Test-and-Treat Reduces HCV Among Gay Men in Swiss HIV Cohort						</a>
					</h4>
					<div class="ja-zinintro">
											</div>

				</div>
			</div>
								
			<div class="ja-zincontent-wrap">
				<div class="ja-zincontent clearfix " >
				
					<div class="ja-zincontent-img" style="float:0">
					<img class="0" src="/images/resized/images/conf-photos/AASLD2017/hoomanfarhangzangneh-p1020335-sq500_60_60.jpg" alt="AASLD 2017: Hepatitis C Testing Linked to Reduced Opioid Use"  />					</div>

					<h4 class="ja-zintitle">
						<a href="/hepatitis-c/hepatitis-c-topics/hcv-prevention/188,673-hcv-injection-drug-use-hcv-injection-drug-use/6169-aasld-2017-hepatitis-c-testing-linked-to-reduced-opioid-use" title="AASLD 2017: Hepatitis C Testing Linked to Reduced Opioid Use">
							AASLD 2017: Hepatitis C Testing Linked to Reduced Opioid Use						</a>
					</h4>
					<div class="ja-zinintro">
											</div>

				</div>
			</div>
								
			<div class="ja-zincontent-wrap">
				<div class="ja-zincontent clearfix " >
				
					<div class="ja-zincontent-img" style="float:0">
					<img class="0" src="/images/resized/images/viruses-Kightly/virus-hbv-group-yellow-sq-400_60_60.jpg" alt="AASLD 2017: Immune Modulator Inarigivir Looks Promising for Hepatitis B"  />					</div>

					<h4 class="ja-zintitle">
						<a href="/hbv-treatment/experimental-hbv-drugs/6171-aasld-2017-immune-modulator-inarigivir-looks-promising-for-people-with-hepatitis-b" title="AASLD 2017: Immune Modulator Inarigivir Looks Promising for Hepatitis B">
							AASLD 2017: Immune Modulator Inarigivir Looks Promising for Hepatitis B						</a>
					</h4>
					<div class="ja-zinintro">
											</div>

				</div>
			</div>
								
			<div class="ja-zincontent-wrap">
				<div class="ja-zincontent clearfix " >
				
					<div class="ja-zincontent-img" style="float:0">
					<img class="0" src="/images/resized/images/conf-photos/AASLD2017/brunosangro-p1020436-sq500_60_60.jpg" alt="AASLD 2017: Nivolumab Improves Outcomes in Liver Cancer Study"  />					</div>

					<h4 class="ja-zintitle">
						<a href="/hcv-disease-progression/hcv-liver-cancer-hcc/6151-aasld-2017-nivolumab-improves-outcomes-in-liver-cancer-study" title="AASLD 2017: Nivolumab Improves Outcomes in Liver Cancer Study">
							AASLD 2017: Nivolumab Improves Outcomes in Liver Cancer Study						</a>
					</h4>
					<div class="ja-zinintro">
											</div>

				</div>
			</div>
									</div>
		</div>
	</div>
	</div>

</div>
</div>
<script type="text/javascript">
/* <![CDATA[ */
	window.addEvent('load', function() {		
		new JANEWSFP_DEFAULT({'moduleid': 160, 'animType': 'animNewsFade', 'duration': 500, 'autoplay':1, 'autoplay_duration':10000});
		$$('.ja-zincontent-wrap').removeClass('hide').removeClass('show');
	});
/* ]]> */	
</script>
<div class="ja-zinwrap default" id="ja-zinwrap-132">
	<div class="ja-zin clearfix">	   
						
			<div class="items-row" style="width: 99.9%">							
					
									
			
					<div class="ja-zinsec clearfix blue">
						
				    					    	<h2>
							<a href="/hiv-aids" title="">
								<span>HIV/AIDS</span>
							</a>
						</h2>
												
						<!-- User setting form -->
						<div class="ja-usersetting-wrap">
<div class="ja-usersetting" id="ja-usersetting-item-132-90">

	<a class="ja-usersetting-loadform" href="javascript:void(0)" onclick="return janewspro.showForm( $('ja-usersetting-item-132-90'))" id="ja-usersetting-loadform-132-90">
		<span>Setting</span>
	</a>
	
	<div class="ja-usersetting-options clearfix" style="overflow: hidden; height: 0; ">
		
		<form class="ja-usersetting-form" method="get" action="index.php" >
			<div class="ja-usersetting-form-inner clearfix">
			<input type="hidden" name="group" value="90" />
			<input type="hidden" name="moduleid" value="132" />
			
						<div class="ja-usersetting-row options-cat clearfix">

			<ul class="checkall">
				<li><input type="checkbox" id="checkall-132-90" name="checkall"  />
				<label for="checkall-132-90">Check all</label></li>
			</ul>
		
			<ul class="catselect">
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="91" id="ja-category-91" name="categories[]" />
					<label for="ja-category-91">HIV Treatment</label>
				</li>
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="272" id="ja-category-272" name="categories[]" />
					<label for="ja-category-272">HIV Prevention </label>
				</li>
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="280" id="ja-category-280" name="categories[]" />
					<label for="ja-category-280">HIV Testing & Diagnosis</label>
				</li>
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="283" id="ja-category-283" name="categories[]" />
					<label for="ja-category-283">HIV Disease Progression</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="300" id="ja-category-300" name="categories[]" />
					<label for="ja-category-300">HIV-Related Conditions</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="289" id="ja-category-289" name="categories[]" />
					<label for="ja-category-289">Side Effects - HIV</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="313" id="ja-category-313" name="categories[]" />
					<label for="ja-category-313">HIV Basic Science</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="331" id="ja-category-331" name="categories[]" />
					<label for="ja-category-331">HIV/AIDS Epidemiology & Mortality</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="318" id="ja-category-318" name="categories[]" />
					<label for="ja-category-318">HIV Populations </label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="335" id="ja-category-335" name="categories[]" />
					<label for="ja-category-335">HIV Policy & Advocacy</label>
				</li>
							</ul>
			</div>
			
			<div class="ja-usersetting-row options-content clearfix">			
				<ul>
					<li>
						<label for="introitems132-90" class="jahasTip" title="Number of intro items will be displayed on frontpage">Intro Items</label>
						<input type="text" name="introitems" id="introitems132-90" value="1" class="inputbox" />
					</li>
					<li>
						<label for="linkitems132-90" class="jahasTip" title="Number of link items will be displayed on frontpage">Link Items</label>
						<input type="text" name="linkitems" id="linkitems132-90" value="3" class="inputbox" />
					</li>
				</ul>
			</div>
			
			<div class="ja-usersetting-row options-img clearfix">
				<ul>
					<li>
						<label class="jahasTip" title="Show/Hide image of article on frontpage">Show Image</label>
					</li>
					<li>
						<input type="radio" name="showimage" id="showimage132-901" value="1"  class="radio" />
						<label for="showimage132-901">Show</label>
					</li>
					<li>
						<input type="radio" name="showimage" id="showimage132-900" value="0" checked="checked" class="radio" />
						<label for="showimage132-900">Hide</label>
					</li>
				</ul>
			</div>
			
			<div class="ja-usersetting-actions clearfix">
				<input type="button" class="button ja-submit" name="ja-submit" value="Save" />
				<input type="button" class="button ja-cancel" name="ja-cancel" value="Cancel" />
			</div>
		</div>
		</form>
	</div>
</div>
</div>						<!-- End -->
									
						 <!-- Group by sub category -->
				    		
				    									
								<div class="item article-column column1 col-first" style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/hiv-aids/hiv-aids-topics/hiv-treatment" title="">
						<span>HIV Treatment</span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/hiv-aids/hiv-aids-topics/hiv-treatment/6185-hivandhepatitiscom-2017-conference-coverage" title="HIVandHepatitis.com 2017 Conference Coverage">HIVandHepatitis.com 2017 Conference Coverage</a>
				</h4>
						
												
								
				<p>
Article listings by topic for HIVandHepatitis.com conference coverage in 2017, i...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="FDA Approves Juluca Dual Single-Tablet Regimen::
	On November 21, the U.S. Food and Drug Administration approved Juluca, a fixed-dose coformulation containing dolutegravir and rilpivirine, for the treatment of adults with HIV who have undetectable viral load on their current antiretroviral regimen. Juluca, a joint product of ViiV Healthcare and...">
				  			<a href="/hiv-treatment/approved-hiv-drugs/6149-fda-approves-juluca-dual-single-tablet-regimen">
				  				FDA Approves Juluca Dual Single-Tablet Regimen				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="Coverage of IDWeek 2017::&lt;p&gt;
	HIVandHepatitis.com coverage of&amp;nbsp;IDWeek&amp;nbsp;2017, held October 4-8, 2017, in San Diego.&lt;/p&gt;
&lt;ul&gt;
	&lt;li&gt;
		&lt;a href=&quot;http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/6125-idweek-2017-long-acting-monoclonal-antibody-effective-against-multidrug-resistant-hiv&quot;&gt;Long-Acting Monoclonal Antibody Effective Against Multidrug-Resistant HIV&lt;/a&gt;&lt;/li&gt;
	&lt;li&gt;
		&lt;a href=&quot;http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/6126-idweek-2017-single-tablet-protease-inhibitor-regimen-maintains-viral-suppression-for-a-year&quot;&gt;Single-Tablet Protease Inhibitor Regimen Maintains Viral Suppression for a Year&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;
	11/30/17&lt;/p&gt;">
				  			<a href="/hiv-aids/hiv-aids-topics/hiv-treatment/6186-coverage-of-idweek-2017">
				  				Coverage of IDWeek 2017				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="EACS 2017: New European Guidelines Cover HIV, Hepatitis C, and Related Conditions::
	Everyone with HIV and hepatitis C virus (HCV) coinfection should receive direct-acting antiviral therapy for hepatitis C and should receive the same treatment regimens for hepatitis C as people with HCV monoinfection, new European guidelines issued at the&amp;nbsp;16th European AIDS Conference...">
				  			<a href="/hiv-aids/hiv-aids-topics/hiv-treatment/6148-eacs-2017-new-european-guidelines-cover-hiv-hepatitis-c-and-associated-conditions2">
				  				EACS 2017: New European Guidelines Cover HIV, Hepatitis C, and Related Conditions				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
														
								<div class="item article-column column2 " style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/hiv-aids/hiv-aids-topics/hiv-prevention" title="">
						<span>HIV Prevention </span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/hiv-aids/hiv-aids-topics/hiv-prevention/6183-eacs-2017-up-to-a-quarter-of-hiv-negative-gay-men-attending-3-english-clinics-used-prep-in-the-last-year" title="EACS 2017: Up to a Quarter of HIV-Negative Gay Men Attending 3 English Clinics Used PrEP in the Last Year">EACS 2017: Up to a Quarter of HIV-Negative Gay Men Attending 3 English Clinics Used PrEP in the Last Year</a>
				</h4>
						
												
								
				<p>
A prospective cohort study of gay men attending 3 clinics in southern England --...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="EACS 2017: HIV Diagnoses in English Gay Men Have Been Falling Since 2014::
	A new analysis by Public Health England of testing rates and HIV diagnoses from all of England&amp;rsquo;s sexual health clinics shows that the decline in diagnoses is England-wide, started at least a year before the decline was first noticed at London&amp;#39;s&amp;nbsp;56 Dean Street&amp;nbsp;clinic, and is...">
				  			<a href="/hiv-aids/hiv-aids-topics/hiv-prevention/6182-eacs-2017-hiv-diagnoses-in-english-gay-men-have-been-falling-since-2014">
				  				EACS 2017: HIV Diagnoses in English Gay Men Have Been Falling Since 2014				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="EACS 2017: High HIV Incidence from Non-Primary Partners and Low PEP and PrEP Use Seen in PARTNER Study::
	HIV incidence among the HIV-negative gay men in the PARTNER 1 and 2 studies, due to sex with partners outside their main relationship, was high, and very high among partners who admitted having condomless anal sex with non-primary partners, researchers reported at the recent 16th European AIDS...">
				  			<a href="/hiv-prevention/hiv-test-treat/6173-eacs-2017-high-hiv-incidence-from-non-primary-partners-and-low-pep-and-prep-use-seen-in-partner-study">
				  				EACS 2017: High HIV Incidence from Non-Primary Partners and Low PEP and PrEP Use Seen in PARTNER Study				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="EACS 2017: Swiss Study Examines When Gay Men Decided to Stop Consistent Condom Use::
	An innovative study presented at the&amp;nbsp;16th European AIDS Conference (EACS 2017)&amp;nbsp;in Milan in October used a machine-learning algorithm (originally developed to help astronomers classify galaxies) to tease out whether there were specific groups of gay men within a large national cohort...">
				  			<a href="/hiv-aids/hiv-aids-topics/hiv-prevention/273,679-hiv-sexual-transmission-hiv-sexual-transmission/6172-eacs-2017-swiss-study-examines-when-gay-men-decided-to-stop-consistent-condom-use">
				  				EACS 2017: Swiss Study Examines When Gay Men Decided to Stop Consistent Condom Use				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
														
								<div class="item article-column column3 " style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/hiv-aids/hiv-aids-topics/hiv-testing-diagnosis" title="">
						<span>HIV Testing & Diagnosis</span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/hiv-aids/hiv-aids-topics/hiv-testing-diagnosis/6145-many-americans-still-get-hiv-diagnosis-years-after-infection-cdc-says2" title="Many Americans Still Get HIV Diagnosis Years After Infection, CDC Says">Many Americans Still Get HIV Diagnosis Years After Infection, CDC Says</a>
				</h4>
						
												
								
				<p>
Many people with HIV in the United States are still being diagnosed with HIV lat...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="CDC Continues to Recommend Annual HIV Testing for Gay Men::
	The U.S. Centers for Disease Control and Prevention (CDC) recently reaffirmed its recommendation that sexually active gay and bisexual men should undergo at least annual HIV screening, according to a report in the August 11 edition of the CDC&amp;#39;s Morbidity and Mortality Weekly Report. However,...">
				  			<a href="/hiv-aids/hiv-aids-topics/hiv-testing-diagnosis/6119-cdc-continues-to-recommend-annual-hiv-testing-for-gay-men">
				  				CDC Continues to Recommend Annual HIV Testing for Gay Men				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="CROI 2017: Point-of-Care Testing Improves Infant HIV Diagnosis Rate, Treatment, and Retention::
	Using a point-of-care test to diagnose HIV in infants significantly improved retention in care, speeded up antiretroviral therapy (ART) initiation, and increased the proportion of infants who started treatment, a large randomized study in Mozambique has found. The results were presented at...">
				  			<a href="/hiv-aids/hiv-aids-topics/hiv-testing-diagnosis/6020-croi-2017-point-of-care-testing-improves-infant-hiv-diagnosis-rate-treatment-and-retention">
				  				CROI 2017: Point-of-Care Testing Improves Infant HIV Diagnosis Rate, Treatment, and Retention				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="CROI 2017: How Should HIV Self-Testing Be Provided?::
	At a session on HIV self-testing at the&amp;nbsp;Conference on Retroviruses and Opportunistic Infections this month&amp;nbsp;in Seattle, researchers presented findings from studies looking at some of the unanswered questions about self-testing and how best to implement it, with examples from Malawi and...">
				  			<a href="/hiv-aids/hiv-aids-topics/hiv-testing-diagnosis/6011-croi-2017-how-should-hiv-self-testing-be-provided">
				  				CROI 2017: How Should HIV Self-Testing Be Provided?				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
														
								<div class="item article-column column4 col-last" style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/hiv-aids/hiv-aids-topics/hiv-disease-progression" title="">
						<span>HIV Disease Progression</span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/hiv-aids/hiv-aids-topics/hiv-disease-progression/6017-croi-2017-hivs-milder-cousin-may-be-less-mild-than-previously-thought" title="CROI 2017: HIV's Milder Cousin May Be Less Mild than Previously Thought">CROI 2017: HIV's Milder Cousin May Be Less Mild than Previously Thought</a>
				</h4>
						
												
								
				<p>
The virulence of HIV-2 virulence may have been underestimated, and although prog...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="Study Sheds New Light on What Happens During Acute HIV Infection::
	An individual&amp;#39;s HIV viral load set-point is generally reached about a month after plasma viremia is first detectable, according to an analysis published in the May 18 online edition of the New England Journal of Medicine. The RV217 study, which included more than 100 people with acute HIV...">
				  			<a href="/hiv-aids/hiv-aids-topics/hiv-disease-progression/284-primary-acute-hiv-primary-acute-hiv/5722-study-sheds-new-light-on-what-happens-during-acute-hiv-infection">
				  				Study Sheds New Light on What Happens During Acute HIV Infection				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="EACS 2015: Does Low-level HIV Viral Load Raise the Risk of Disease Progression and Comorbidities?::
	HIV-positive people with detectable but low viral load -- in the range of 50 to 500 or 1000 copies/mL -- may continue to have a higher risk of AIDS-related events, but their likelihood of experiencing serious non-AIDS events including heart, liver, and kidney disease did not appear to increase,...">
				  			<a href="/hiv-aids/hiv-aids-topics/hiv-disease-progression/5468-eacs-2015-does-low-level-hiv-viral-load-raise-the-risk-of-disease-progression-and-comorbidities">
				  				EACS 2015: Does Low-level HIV Viral Load Raise the Risk of Disease Progression and Comorbidities?				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="IAS 2015: Many People with Long-term HIV Infection Do Not Achieve Full CD4 Cell Recovery::
	One-third of people who started combination antiretroviral therapy (ART) many years ago using first-generation protease inhibitors did not achieve complete immunological recovery with normal CD4 T-cell counts despite good viral suppression, according to a French study presented at the recent 8th...">
				  			<a href="/hiv-aids/hiv-aids-topics/hiv-disease-progression/5359-ias-2015-many-people-with-long-term-hiv-infection-do-not-achieve-full-cd4-cell-recovery">
				  				IAS 2015: Many People with Long-term HIV Infection Do Not Achieve Full CD4 Cell Recovery				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
											    		
				    					    </div>
				
				
									
									
			
					<div class="ja-zinsec clearfix purple">
						
				    					    	<h2>
							<a href="/hepatitis-b" title="">
								<span>Hepatitis B</span>
							</a>
						</h2>
												
						<!-- User setting form -->
						<div class="ja-usersetting-wrap">
<div class="ja-usersetting" id="ja-usersetting-item-132-97">

	<a class="ja-usersetting-loadform" href="javascript:void(0)" onclick="return janewspro.showForm( $('ja-usersetting-item-132-97'))" id="ja-usersetting-loadform-132-97">
		<span>Setting</span>
	</a>
	
	<div class="ja-usersetting-options clearfix" style="overflow: hidden; height: 0; ">
		
		<form class="ja-usersetting-form" method="get" action="index.php" >
			<div class="ja-usersetting-form-inner clearfix">
			<input type="hidden" name="group" value="97" />
			<input type="hidden" name="moduleid" value="132" />
			
						<div class="ja-usersetting-row options-cat clearfix">

			<ul class="checkall">
				<li><input type="checkbox" id="checkall-132-97" name="checkall"  />
				<label for="checkall-132-97">Check all</label></li>
			</ul>
		
			<ul class="catselect">
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="98" id="ja-category-98" name="categories[]" />
					<label for="ja-category-98">HBV Treatment</label>
				</li>
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="358" id="ja-category-358" name="categories[]" />
					<label for="ja-category-358">HBV Prevention</label>
				</li>
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="362" id="ja-category-362" name="categories[]" />
					<label for="ja-category-362">HBV Testing & Diagnosis</label>
				</li>
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="365" id="ja-category-365" name="categories[]" />
					<label for="ja-category-365">HBV Disease Progression</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="372" id="ja-category-372" name="categories[]" />
					<label for="ja-category-372">HBV-Related Conditions</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="364" id="ja-category-364" name="categories[]" />
					<label for="ja-category-364">Side Effects - HBV</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="373" id="ja-category-373" name="categories[]" />
					<label for="ja-category-373">HBV Basic Science</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="385" id="ja-category-385" name="categories[]" />
					<label for="ja-category-385">HBV Epidemiology & Mortality</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="376" id="ja-category-376" name="categories[]" />
					<label for="ja-category-376">HBV Populations</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="386" id="ja-category-386" name="categories[]" />
					<label for="ja-category-386">HBV Policy & Advocacy</label>
				</li>
							</ul>
			</div>
			
			<div class="ja-usersetting-row options-content clearfix">			
				<ul>
					<li>
						<label for="introitems132-97" class="jahasTip" title="Number of intro items will be displayed on frontpage">Intro Items</label>
						<input type="text" name="introitems" id="introitems132-97" value="1" class="inputbox" />
					</li>
					<li>
						<label for="linkitems132-97" class="jahasTip" title="Number of link items will be displayed on frontpage">Link Items</label>
						<input type="text" name="linkitems" id="linkitems132-97" value="3" class="inputbox" />
					</li>
				</ul>
			</div>
			
			<div class="ja-usersetting-row options-img clearfix">
				<ul>
					<li>
						<label class="jahasTip" title="Show/Hide image of article on frontpage">Show Image</label>
					</li>
					<li>
						<input type="radio" name="showimage" id="showimage132-971" value="1"  class="radio" />
						<label for="showimage132-971">Show</label>
					</li>
					<li>
						<input type="radio" name="showimage" id="showimage132-970" value="0" checked="checked" class="radio" />
						<label for="showimage132-970">Hide</label>
					</li>
				</ul>
			</div>
			
			<div class="ja-usersetting-actions clearfix">
				<input type="button" class="button ja-submit" name="ja-submit" value="Save" />
				<input type="button" class="button ja-cancel" name="ja-cancel" value="Cancel" />
			</div>
		</div>
		</form>
	</div>
</div>
</div>						<!-- End -->
									
						 <!-- Group by sub category -->
				    		
				    									
								<div class="item article-column column1 col-first" style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/hepatitis-b/hepatitis-b-topics/hbv-treatment" title="">
						<span>HBV Treatment</span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/hbv-treatment/experimental-hbv-drugs/6177-aasld-2017-treatment-that-interferes-with-viral-assembly-shows-promise-for-hepatitis-b" title="AASLD 2017: Treatment that Interferes with Viral Assembly Shows Promise for Hepatitis B">AASLD 2017: Treatment that Interferes with Viral Assembly Shows Promise for Hepatitis B</a>
				</h4>
						
												
								
				<p>
JNJ-56136379, an experimental drug that interferes with assembly of the hepatiti...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="AASLD 2017: RNA Interference Therapy Lowers Viral Biomarker in People with Hepatitis B::&lt;p&gt;
	ARB-1467, a novel type of treatment for hepatitis B, reduced levels of hepatitis B surface antigen (HBsAg) when used alone, and it may play a role in combination therapy to cure the infection, researchers reported at the recent 2017 AASLD Liver Meeting in Washington, DC.&lt;/p&gt;
&lt;p&gt;
	&lt;/p&gt;">
				  			<a href="/hbv-treatment/experimental-hbv-drugs/6176-aasld-2017-rna-interference-therapy-lowers-viral-biomarker-in-people-with-hepatitis-b">
				  				AASLD 2017: RNA Interference Therapy Lowers Viral Biomarker in People with Hepatitis B				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="AASLD 2017: TAF for Hepatitis B Improves Kidney Function and Bone Loss::&lt;p&gt;
	Tenofovir alafenamide (TAF) remains effective against hepatitis B virus (HBV) for 96 weeks, with no resistance detected, according to studies presented at the 2017 AASLD Liver Meeting last month in Washington, DC.&lt;/p&gt;
&lt;p&gt;
	&lt;/p&gt;">
				  			<a href="/hepatitis-b/hepatitis-b-topics/hbv-treatment/6153-aasld-2017-taf-for-hepatitis-b-improves-kidney-function-and-bone-loss">
				  				AASLD 2017: TAF for Hepatitis B Improves Kidney Function and Bone Loss				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="AASLD 2017: TAF for Hepatitis B Improves Kidney Function and Bone Loss::&lt;p&gt;
	Tenofovir alafenamide (TAF) remains effective against hepatitis B virus (HBV) for 96 weeks, with no resistance detected, according to studies presented at the 2017 AASLD Liver Meeting last month in Washington, DC.&lt;/p&gt;
&lt;p&gt;
	&lt;/p&gt;">
				  			<a href="/hepatitis-b/hepatitis-b-topics/hbv-treatment/6154-aasld-2017-taf-for-hepatitis-b-improves-kidney-function-and-bone-loss">
				  				AASLD 2017: TAF for Hepatitis B Improves Kidney Function and Bone Loss				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
														
								<div class="item article-column column2 " style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/hepatitis-b/hepatitis-b-topics/hbv-prevention" title="">
						<span>HBV Prevention</span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/hbv-prevention/hbv-vaccines/6158-us-approves-new-hepatitis-b-vaccine-as-public-health-agencies-update-guidelines" title="U.S. Approves New Hepatitis B Vaccine as Public Health Agencies Update Guidelines">U.S. Approves New Hepatitis B Vaccine as Public Health Agencies Update Guidelines</a>
				</h4>
						
												
								
				<p>
On November 9 the U.S. Food and Drug Administration(FDA) approved Heplisav-B, a ...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="PAS 2017: Children on Immunosuppressive Therapy May Lose Hepatitis B Vaccine Protection::
	More than half of children treated with immunosuppressive drugs for gastrointestinal or rheumatological conditions no longer had protective levels of antibodies against hepatitis B virus (HBV) and may require repeat vaccinations, according to a study presented at the Pediatric Academic Societies...">
				  			<a href="/hbv-prevention/hbv-vaccines/6065-pas-2017-children-on-immunosuppressive-therapy-may-lose-hepatitis-b-vaccine-protection">
				  				PAS 2017: Children on Immunosuppressive Therapy May Lose Hepatitis B Vaccine Protection				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="Telbivudine Prevents Mother-to-Child Hepatitis B Virus Transmission::
	Women with a high hepatitis B viral load who were treated with the antiviral drug&amp;nbsp;telbivudine&amp;nbsp;(Tyzeka) had a lower risk of transmitting the virus to their babies during pregnancy or birth -- in fact, none did so -- compared to untreated women whose infants only received...">
				  			<a href="/hepatitis-b/hepatitis-b-topics/hbv-prevention/5256-telbivudine-prevents-mother-to-child-transmission-of-hepatitis-b-virus">
				  				Telbivudine Prevents Mother-to-Child Hepatitis B Virus Transmission				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="HIV Controllers Respond Better to Hepatitis B Vaccine::
	HIV positive natural controllers who maintain undetectable or low viral load without&amp;nbsp;antiretroviral&amp;nbsp;therapy (ART) are more likely to achieve adequate response to hepatitis B virus (HBV) vaccination and have improved survival, according to a study published in the&amp;nbsp;August 21 edition...">
				  			<a href="/hbv-prevention/hbv-vaccines/4845-hiv-controllers-respond-better-to-hepatitis-b-vaccine">
				  				HIV Controllers Respond Better to Hepatitis B Vaccine				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
														
								<div class="item article-column column3 " style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/hepatitis-b/hepatitis-b-topics/hbv-testing-diagnosis" title="">
						<span>HBV Testing & Diagnosis</span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/hepatitis-b/hepatitis-b-topics/hbv-testing-diagnosis/4933-aasld-2014-hepatitis-b-testing-and-treatment-rates-are-low-among-us-veterans" title="AASLD 2014: Hepatitis B Testing and Treatment Rates Are Low Among U.S. Veterans">AASLD 2014: Hepatitis B Testing and Treatment Rates Are Low Among U.S. Veterans</a>
				</h4>
						
												
								
				<p>
Only 15% of U.S. veterans have been tested for hepatitis B virus (HBV) infection...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="Prevention Task Force Recommends Hepatitis B Screening for People at High Risk::
	The U.S. Preventive Services Task Force (USPSTF) last week issued a new recommendation for hepatitis B virus (HBV) screening of non-pregnant adolescents and adults without current symptoms of viral hepatitis. The task force called for screening of people at high risk for infection including...">
				  			<a href="/hepatitis-b/hepatitis-b-topics/hbv-testing-diagnosis/4705-prevention-task-force-recommends-hepatitis-b-screening-for-people-at-high-risk">
				  				Prevention Task Force Recommends Hepatitis B Screening for People at High Risk				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="New Guidelines for Hepatitis B Screening::
	U.S. Preventive Services Task Force this week released updated guidelines for hepatitis B virus (HBV) screening for adults. The draft recommendations call for screening of high-risk individuals including people with HIV, gay men, people who inject drugs, and people from parts of the world where...">
				  			<a href="/hepatitis-b/hepatitis-b-topics/hbv-testing-diagnosis/4521-new-guidelines-for-hepatitis-b-screening">
				  				New Guidelines for Hepatitis B Screening				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="National Hepatitis Testing Day: Most Infected Are Unaware, All Boomers Should Get HCV Test::
	In advance of the National Hepatitis Testing Day on Saturday, May 19, the U.S. Centers for Disease Control and Prevention (CDC) has issued a new recommendation that all Baby Boomers born between 1945 and 1965 should get tested at least once for hepatitis C. Testing Day events will also promote...">
				  			<a href="/hepatitis-b/hepatitis-b-topics/hbv-testing-diagnosis/3595-may-19-is-hepatitis-testing-day-most-with-hbv-or-hcv-are-unaware">
				  				National Hepatitis Testing Day: Most Infected Are Unaware, All Boomers Should Get HCV Test				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
														
								<div class="item article-column column4 col-last" style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/hepatitis-b/hepatitis-b-topics/hbv-disease-progression" title="">
						<span>HBV Disease Progression</span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/hbv-disease-progression/hbv-liver-cancer-hcc/6141-aasld-2017-daily-aspirin-linked-to-lower-liver-cancer-risk-for-hepatitis-b-patients" title="AASLD 2017: Daily Aspirin Linked to Lower Liver Cancer Risk for Hepatitis B Patients">AASLD 2017: Daily Aspirin Linked to Lower Liver Cancer Risk for Hepatitis B Patients</a>
				</h4>
						
												
								
				<p>
People with hepatitis B virus (HBV) who took an aspirin a day -- often recommend...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="FDA Approves Nivolumab Immunotherapy for Liver Cancer::&lt;p&gt;
	In September, the U.S. Food and Drug Administration granted accelerated approval for nivolumab (Opdivo), an immunotherapy drug that restores T-cell anti-tumor activity, for people with hepatocellular carcinoma (HCC).&lt;/p&gt;
&lt;p&gt;
	&lt;/p&gt;">
				  			<a href="/hbv-disease-progression/hbv-liver-cancer-hcc/6130-fda-approves-nivolumab-immunotherapy-for-liver-cancer">
				  				FDA Approves Nivolumab Immunotherapy for Liver Cancer				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="FDA Approves Nivolumab Immunotherapy for Liver Cancer::&lt;p&gt;
	In September, the U.S. Food and Drug Administrationgranted accelerated approval for nivolumab (Opdivo), an immunotherapy drug that restores T-cell anti-tumor activity, for people with hepatocellular carcinoma (HCC).&lt;/p&gt;
&lt;p&gt;
	&lt;/p&gt;">
				  			<a href="/hbv-disease-progression/hbv-liver-cancer-hcc/6131-fda-approves-nivolumab-immunotherapy-for-liver-cancer2">
				  				FDA Approves Nivolumab Immunotherapy for Liver Cancer				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="EASL 2017: Albumin Reduces Complications of Decompensated Cirrhosis and Improves Survival::&lt;p&gt;
	Long-term administration of human album was associated with fewer serious complications, less hospitalization, better quality of life, and longer survival for people with decompensated liver cirrhosis, according to a report at the EASL International Liver Congress last month in Amsterdam.&lt;/p&gt;
&lt;p&gt;
	&lt;/p&gt;">
				  			<a href="/hepatitis-b/hepatitis-b-topics/hbv-disease-progression/369,453,674-hbv-decompensation-esld-hbv-decompensation-esld/6057-easl-2017-albumin-reduces-complications-of-decompensated-cirrhosis-and-improves-survival">
				  				EASL 2017: Albumin Reduces Complications of Decompensated Cirrhosis and Improves Survival				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
											    		
				    					    </div>
				
				
									
									
			
					<div class="ja-zinsec clearfix green">
						
				    					    	<h2>
							<a href="/hepatitis-c" title="">
								<span>Hepatitis C</span>
							</a>
						</h2>
												
						<!-- User setting form -->
						<div class="ja-usersetting-wrap">
<div class="ja-usersetting" id="ja-usersetting-item-132-104">

	<a class="ja-usersetting-loadform" href="javascript:void(0)" onclick="return janewspro.showForm( $('ja-usersetting-item-132-104'))" id="ja-usersetting-loadform-132-104">
		<span>Setting</span>
	</a>
	
	<div class="ja-usersetting-options clearfix" style="overflow: hidden; height: 0; ">
		
		<form class="ja-usersetting-form" method="get" action="index.php" >
			<div class="ja-usersetting-form-inner clearfix">
			<input type="hidden" name="group" value="104" />
			<input type="hidden" name="moduleid" value="132" />
			
						<div class="ja-usersetting-row options-cat clearfix">

			<ul class="checkall">
				<li><input type="checkbox" id="checkall-132-104" name="checkall"  />
				<label for="checkall-132-104">Check all</label></li>
			</ul>
		
			<ul class="catselect">
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="105" id="ja-category-105" name="categories[]" />
					<label for="ja-category-105">HCV Treatment</label>
				</li>
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="106" id="ja-category-106" name="categories[]" />
					<label for="ja-category-106">HCV Prevention</label>
				</li>
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="107" id="ja-category-107" name="categories[]" />
					<label for="ja-category-107">HCV Testing & Diagnosis</label>
				</li>
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="448" id="ja-category-448" name="categories[]" />
					<label for="ja-category-448">HCV Disease Progression</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="455" id="ja-category-455" name="categories[]" />
					<label for="ja-category-455">HCV-Related Conditions</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="179" id="ja-category-179" name="categories[]" />
					<label for="ja-category-179">Side Effects - HCV</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="456" id="ja-category-456" name="categories[]" />
					<label for="ja-category-456">HCV Basic Science</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="468" id="ja-category-468" name="categories[]" />
					<label for="ja-category-468">HCV Epidemiology & Mortality</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="503" id="ja-category-503" name="categories[]" />
					<label for="ja-category-503">HCV Populations</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="469" id="ja-category-469" name="categories[]" />
					<label for="ja-category-469">HCV Policy & Advocacy</label>
				</li>
							</ul>
			</div>
			
			<div class="ja-usersetting-row options-content clearfix">			
				<ul>
					<li>
						<label for="introitems132-104" class="jahasTip" title="Number of intro items will be displayed on frontpage">Intro Items</label>
						<input type="text" name="introitems" id="introitems132-104" value="1" class="inputbox" />
					</li>
					<li>
						<label for="linkitems132-104" class="jahasTip" title="Number of link items will be displayed on frontpage">Link Items</label>
						<input type="text" name="linkitems" id="linkitems132-104" value="3" class="inputbox" />
					</li>
				</ul>
			</div>
			
			<div class="ja-usersetting-row options-img clearfix">
				<ul>
					<li>
						<label class="jahasTip" title="Show/Hide image of article on frontpage">Show Image</label>
					</li>
					<li>
						<input type="radio" name="showimage" id="showimage132-1041" value="1"  class="radio" />
						<label for="showimage132-1041">Show</label>
					</li>
					<li>
						<input type="radio" name="showimage" id="showimage132-1040" value="0" checked="checked" class="radio" />
						<label for="showimage132-1040">Hide</label>
					</li>
				</ul>
			</div>
			
			<div class="ja-usersetting-actions clearfix">
				<input type="button" class="button ja-submit" name="ja-submit" value="Save" />
				<input type="button" class="button ja-cancel" name="ja-cancel" value="Cancel" />
			</div>
		</div>
		</form>
	</div>
</div>
</div>						<!-- End -->
									
						 <!-- Group by sub category -->
				    		
				    									
								<div class="item article-column column1 col-first" style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/hepatitis-c/hepatitis-c-topics/hcv-treatment" title="">
						<span>HCV Treatment</span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/hepatitis-c/hepatitis-c-topics/hcv-treatment/6152-aasld-2017-more-work-and-lower-drug-prices-needed-to-eliminate-hepatitis-c-worldwide" title="AASLD 2017: More Work and Lower Drug Prices Needed to Eliminate Hepatitis C Worldwide">AASLD 2017: More Work and Lower Drug Prices Needed to Eliminate Hepatitis C Worldwide</a>
				</h4>
						
												
								
				<p>
Eliminating hepatitis C virus (HCV) as a global public health concern is feasibl...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="AASLD 2017: Sofosbuvir/Ledipasvir for 8 Weeks Cures Acute HCV in People with HIV::&lt;p&gt;
	An 8-week course of sofosbuvir/ledipasvir (Harvoni) led to sustained response in all HIV-positive with genotype 1 or 4 acute hepatitis C virus (HCV) infection in the SWIFT-C study, according to a reportat the AASLD Liver Meeting last month in Washington, DC.&lt;/p&gt;
&lt;p&gt;
	&lt;/p&gt;">
				  			<a href="/hepatitis-c/hepatitis-c-topics/hcv-treatment/6155-aasld-2017-sofosbuvirledipasvir-for-8-weeks-cures-acute-hcv-in-people-with-hiv">
				  				AASLD 2017: Sofosbuvir/Ledipasvir for 8 Weeks Cures Acute HCV in People with HIV				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="AASLD 2017: Sofosbuvir/Ledipasvir for 8 Weeks Cures Acute HCV in People with HIV::&lt;p&gt;
	An 8-week course of sofosbuvir/ledipasvir (Harvoni) led to sustained response in all HIV-positive with genotype 1 or 4 acute hepatitis C virus (HCV) infection in the SWIFT-C study, according to a reportat the AASLD Liver Meeting last month in Washington, DC.&lt;/p&gt;
&lt;p&gt;
	&lt;/p&gt;">
				  			<a href="/hepatitis-c/hepatitis-c-topics/hcv-treatment/6156-aasld-2017-sofosbuvirledipasvir-for-8-weeks-cures-acute-hcv-in-people-with-hiv">
				  				AASLD 2017: Sofosbuvir/Ledipasvir for 8 Weeks Cures Acute HCV in People with HIV				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="AASLD 2017: Model Shows Hepatitis C Treatment is Cost-Effective in Japan::&lt;p&gt;
	Treatment of chronic hepatitis C with direct-acting antivirals can lead to substantial savings by preventing the development of liver failure and liver cancer, according to a mathematical modeling study presented at the AASLD Liver Meeting in October in Washington, DC.&lt;/p&gt;
&lt;p&gt;
	&lt;/p&gt;">
				  			<a href="/hepatitis-c/hepatitis-c-topics/hcv-treatment/6175-aasld-2017-model-shows-hepatitis-c-treatment-is-cost-effective-in-japan">
				  				AASLD 2017: Model Shows Hepatitis C Treatment is Cost-Effective in Japan				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
														
								<div class="item article-column column2 " style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/hepatitis-c/hepatitis-c-topics/hcv-prevention" title="">
						<span>HCV Prevention</span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/hcv-prevention/hcv-sexual-transmission/6140-aasld-2017-hcv-infections-are-rising-among-hiv-gay-men-in-san-diego" title="AASLD 2017: HCV Infections Are Rising Among HIV+ Gay Men In San Diego">AASLD 2017: HCV Infections Are Rising Among HIV+ Gay Men In San Diego</a>
				</h4>
						
												
								
				<p>
Hepatitis C incidence is increasing among gay and bisexual men living with HIV i...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="EACS 2017: High Rate of Hepatitis C Reinfection in German Men Who Have Sex With Men::
	Around 1 in 7 gay and bisexual men cured of hepatitis C at major treatment centers in Germany have become reinfected since 2014, according to findings from the German Hepatitis C Cohort presented at the&amp;nbsp;16th European AIDS Conference (EACS 2017)&amp;nbsp;in Milan in October. At least half of...">
				  			<a href="/hcv-prevention/hcv-sexual-transmission/6179-eacs-2017-high-rate-of-hepatitis-c-reinfection-in-german-men-who-have-sex-with-men">
				  				EACS 2017: High Rate of Hepatitis C Reinfection in German Men Who Have Sex With Men				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="Does Drug Injection Equipment Other than Syringes Transmit Hepatitis C?::&lt;p&gt;
	Sharing drug preparation paraphernalia may not significantly contribute to hepatitis C virus (HCV) transmission among people who inject drugs, according to a study &lt;a href=&quot;https://academic.oup.com/jid/article-abstract/doi/10.1093/infdis/jix427/4085610/Recovery-of-Infectious-Hepatitis-C-Virus-from&quot;&gt;recently published in the &lt;em&gt;Journal of Infectious Diseases&lt;/em&gt;&lt;/a&gt;&lt;em&gt;.&lt;/em&gt;&lt;/p&gt;
&lt;p&gt;
	&lt;/p&gt;">
				  			<a href="/hepatitis-c/hepatitis-c-topics/hcv-prevention/188-hcv-injection-drug-use-hcv-injection-drug-use/6120-does-drug-injection-equipment-other-than-syringes-transmit-hepatitis-c">
				  				Does Drug Injection Equipment Other than Syringes Transmit Hepatitis C?				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="CROI 2017: New HCV Infections Among HIV+ Gay Men Drop By Half After DAA Roll-Out in Netherlands::
	A little more than a year after the Netherlands instituted a policy allowing unrestricted access to direct-acting antivirals (DAAs) for the hepatitis C treatment, researchers have already seen a dramatic decline in acute HCV infections among one at-risk population, HIV-positive men who have sex...">
				  			<a href="/hcv-prevention/hcv-sexual-transmission/5992-croi-2017-new-hcv-infections-among-hiv-gay-men-drop-by-half-after-daa-roll-out-in-netherlands">
				  				CROI 2017: New HCV Infections Among HIV+ Gay Men Drop By Half After DAA Roll-Out in Netherlands				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
														
								<div class="item article-column column3 " style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/hcv-testing-diagnosis" title="">
						<span>HCV Testing & Diagnosis</span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/hcv-testing-diagnosis/5935-aasld-2016-birth-cohort-screening-and-linkage-to-hepatitis-c-care-still-weak-in-us" title="AASLD 2016: Birth Cohort Screening and Linkage to Hepatitis C Care Still Weak in U.S.">AASLD 2016: Birth Cohort Screening and Linkage to Hepatitis C Care Still Weak in U.S.</a>
				</h4>
						
												
								
				<p>
Grave weaknesses in hepatitis C virus (HCV) screening and linkage to care are st...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="Hepatitis C Antigen Testing Could Eliminate Need for 2-Step HCV Testing::
	Testing for hepatitis C virus (HCV) core antigen could eventually replace the current 2-step procedure for diagnosing chronic hepatitis C infection in lower- and middle-income countries, speeding up access to treatment and improving retention in care, a systematic review designed to inform World...">
				  			<a href="/hcv-testing-diagnosis/5754-hepatitis-c-antigen-testing-could-eliminate-need-for-2-step-hcv-testing">
				  				Hepatitis C Antigen Testing Could Eliminate Need for 2-Step HCV Testing				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="May is Hepatitis Awareness Month -- Hepatitis Testing Day on May 19::
	May has been designated as Hepatitis Awareness Month in the U.S., an opportunity to raise awareness about viral hepatitis and to encourage testing and treatment. May 19 is the fifth annual observance of Hepatitis Testing Day, reminding health care providers and the public that more than half of...">
				  			<a href="/hcv-testing-diagnosis/5713-may-is-hepatitis-awareness-month-hepatitis-testing-day-on-may-19">
				  				May is Hepatitis Awareness Month -- Hepatitis Testing Day on May 19				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="Testing in Oakland Emergency Department Reveals High Rate of Hepatitis C Virus Infection::
	Hepatitis C screening at an urban emergency department revealed that 10% of patients overall had evidence of hepatitis C virus (HCV) infection -- of whom more than two-thirds had active infection -- rising to 25% among homeless people and nearly 40% among people who inject drugs, according to a...">
				  			<a href="/hcv-testing-diagnosis/5377-testing-in-oakland-emergency-department-reveals-high-rate-of-hepatitis-c-virus-infection">
				  				Testing in Oakland Emergency Department Reveals High Rate of Hepatitis C Virus Infection				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
														
								<div class="item article-column column4 col-last" style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/hepatitis-c/hepatitis-c-topics/hcv-disease-progression" title="">
						<span>HCV Disease Progression</span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/hcv-disease-progression/hcv-liver-cancer-hcc/6139-aasld-2017-curing-hepatitis-c-with-daas-reduces-liver-cancer-risk" title="AASLD 2017: Curing Hepatitis C with DAAs Reduces Liver Cancer Risk">AASLD 2017: Curing Hepatitis C with DAAs Reduces Liver Cancer Risk</a>
				</h4>
						
												
								
				<p>
People who achieved a sustained virological response to hepatitis C treatment lo...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="EASL 2017: Hepatitis C Treatment Allows 1 in 4 to Come Off Liver Transplant Waiting List::
	Around a quarter of people with hepatitis C and decompensated cirrhosis came off liver transplant waiting lists in Europe after direct-acting antiviral (DAA) treatment, and very few had any subsequent liver-related problems during 15 months of follow-up, Luca Belli reported on behalf of the...">
				  			<a href="/hcv-disease-progression/hcv-liver-cancer-hcc/6055-easl-2017-hepatitis-c-treatment-allows-1-in-4-to-come-off-liver-transplant-waiting-list">
				  				EASL 2017: Hepatitis C Treatment Allows 1 in 4 to Come Off Liver Transplant Waiting List				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="EASL 2017: Direct-Acting Antivirals for Hepatitis C Not Linked to Higher Liver Cancer Risk::
	Hepatitis C patients treated with direct-acting antivirals (DAAs) do not appear to have a higher risk of developing liver cancer compared to those treated with interferon, and the seemingly higher rates seen in some studies are attributable to risk factors such as older age and more advanced...">
				  			<a href="/hepatitis-c/hepatitis-c-topics/hcv-disease-progression/6043-easl-2017-direct-acting-antivirals-for-hepatitis-c-not-linked-to-higher-liver-cancer-risk-in-most-studies">
				  				EASL 2017: Direct-Acting Antivirals for Hepatitis C Not Linked to Higher Liver Cancer Risk				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="CROI 2017: Are HIV/HCV Coinfected People Cured with DAAs at Increased Risk for Liver Cancer?::
	HIV/HCV coinfected people who are successfully treated for hepatitis C using interferon-free direct-acting antiviral (DAA) therapy do not appear to have an increased likelihood of developing hepatocellular carcinoma (HCC), according to a study presented at the Conference on Retroviruses and...">
				  			<a href="/hepatitis-c/hepatitis-c-topics/hcv-disease-progression/6006-croi-2017-are-hivhcv-coinfected-people-cured-of-hepatitis-c-with-daas-at-increased-risk-for-liver-cancer">
				  				CROI 2017: Are HIV/HCV Coinfected People Cured with DAAs at Increased Risk for Liver Cancer?				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
											    		
				    					    </div>
				
				
									
									
			
					<div class="ja-zinsec clearfix orange">
						
				    					    	<h2>
							<a href="/hiv-hep-coinfection" title="">
								<span>HIV/Hepatitis Coinfection</span>
							</a>
						</h2>
												
						<!-- User setting form -->
						<div class="ja-usersetting-wrap">
<div class="ja-usersetting" id="ja-usersetting-item-132-108">

	<a class="ja-usersetting-loadform" href="javascript:void(0)" onclick="return janewspro.showForm( $('ja-usersetting-item-132-108'))" id="ja-usersetting-loadform-132-108">
		<span>Setting</span>
	</a>
	
	<div class="ja-usersetting-options clearfix" style="overflow: hidden; height: 0; ">
		
		<form class="ja-usersetting-form" method="get" action="index.php" >
			<div class="ja-usersetting-form-inner clearfix">
			<input type="hidden" name="group" value="108" />
			<input type="hidden" name="moduleid" value="132" />
			
						<div class="ja-usersetting-row options-cat clearfix">

			<ul class="checkall">
				<li><input type="checkbox" id="checkall-132-108" name="checkall"  />
				<label for="checkall-132-108">Check all</label></li>
			</ul>
		
			<ul class="catselect">
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="194" id="ja-category-194" name="categories[]" />
					<label for="ja-category-194">HIV/HBV Coinfection</label>
				</li>
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="197" id="ja-category-197" name="categories[]" />
					<label for="ja-category-197">HIV/HCV Coinfection</label>
				</li>
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="551" id="ja-category-551" name="categories[]" />
					<label for="ja-category-551">HBV/HCV Coinfection</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="552" id="ja-category-552" name="categories[]" />
					<label for="ja-category-552">HIV/HBV/HCV Triple Infection</label>
				</li>
							</ul>
			</div>
			
			<div class="ja-usersetting-row options-content clearfix">			
				<ul>
					<li>
						<label for="introitems132-108" class="jahasTip" title="Number of intro items will be displayed on frontpage">Intro Items</label>
						<input type="text" name="introitems" id="introitems132-108" value="1" class="inputbox" />
					</li>
					<li>
						<label for="linkitems132-108" class="jahasTip" title="Number of link items will be displayed on frontpage">Link Items</label>
						<input type="text" name="linkitems" id="linkitems132-108" value="3" class="inputbox" />
					</li>
				</ul>
			</div>
			
			<div class="ja-usersetting-row options-img clearfix">
				<ul>
					<li>
						<label class="jahasTip" title="Show/Hide image of article on frontpage">Show Image</label>
					</li>
					<li>
						<input type="radio" name="showimage" id="showimage132-1081" value="1"  class="radio" />
						<label for="showimage132-1081">Show</label>
					</li>
					<li>
						<input type="radio" name="showimage" id="showimage132-1080" value="0" checked="checked" class="radio" />
						<label for="showimage132-1080">Hide</label>
					</li>
				</ul>
			</div>
			
			<div class="ja-usersetting-actions clearfix">
				<input type="button" class="button ja-submit" name="ja-submit" value="Save" />
				<input type="button" class="button ja-cancel" name="ja-cancel" value="Cancel" />
			</div>
		</div>
		</form>
	</div>
</div>
</div>						<!-- End -->
									
						 <!-- Group by sub category -->
				    		
				    									
								<div class="item article-column column1 col-first" style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/hiv-hep-coinfection/hiv-hbv-coinfection" title="">
						<span>HIV/HBV Coinfection</span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/hiv-hep-coinfection/hiv-hbv-coinfection/5819-aids-2016-ongoing-hepatitis-b-virus-replication-raises-mortality-for-people-with-hiv" title="AIDS 2016: Ongoing Hepatitis B Virus Replication Raises Mortality for People with HIV">AIDS 2016: Ongoing Hepatitis B Virus Replication Raises Mortality for People with HIV</a>
				</h4>
						
												
								
				<p>
People with HIV and hepatitis B virus (HBV) coinfection have more than double th...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="CROI 2016: HIV/HBV Coinfection Linked to Worse Immune Recovery and Death::
	HIV-positive people with hepatitis B virus (HBV)&amp;nbsp;coinfection&amp;nbsp;had impaired&amp;nbsp;CD4&amp;nbsp;cell recovery after starting&amp;nbsp;antiretroviral&amp;nbsp;(ART) and a higher risk of death than those without hepatitis B, but use of ART regimens containing&amp;nbsp;tenofovir&amp;nbsp;significantly reduced...">
				  			<a href="/hiv-hep-coinfection/hiv-hbv-coinfection/5657-croi-2016-hivhbv-coinfection-linked-to-impaired-immune-response-and-death-in-kenya">
				  				CROI 2016: HIV/HBV Coinfection Linked to Worse Immune Recovery and Death				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="Antiretroviral Treatment for HIV Appears to Protect Gay Men Against Hepatitis B::
	HIV-positive gay and bisexual men who use effective combination antiretroviral therapy (ART) were 80% less likely to become infected with hepatitis B virus (HBV) in a large observational study reported in the October 13 Annals of Internal Medicine. The authors emphasize, however, that ART is not...">
				  			<a href="/hiv-hep-coinfection/hiv-hbv-coinfection/5431-antiretroviral-treatment-for-hiv-appears-to-protects-gay-men-against-hepatitis-b-3">
				  				Antiretroviral Treatment for HIV Appears to Protect Gay Men Against Hepatitis B				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="Tenofovir-containing Regimen Works Better Over Time for HIV/HBV Coinfected People::
	HIV-positive people coinfected with hepatitis B virus (HBV) who were treated with 2 dually-active drugs -- one of them being tenofovir -- responded about as well as people taking only lamivudine or emtricitabine at 24 weeks, but over the longer term those on tenofovir plus either lamivudine or...">
				  			<a href="/hiv-hep-coinfection/hiv-hbv-coinfection/5386-tenofovir-containing-regimen-works-better-over-time-for-hivhepatitis-b-coinfected-people">
				  				Tenofovir-containing Regimen Works Better Over Time for HIV/HBV Coinfected People				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
														
								<div class="item article-column column2 " style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/hiv-hep-coinfection/hiv-hcv-coinfection" title="">
						<span>HIV/HCV Coinfection</span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/hiv-hep-coinfection/hiv-hcv-coinfection/6136-eacs-2017-hepatitis-c-halved-among-spanish-people-with-hiv-thanks-to-hcv-treatment" title="EACS 2017: Hepatitis C Halved among Spanish People with HIV Thanks to HCV Treatment">EACS 2017: Hepatitis C Halved among Spanish People with HIV Thanks to HCV Treatment</a>
				</h4>
						
												
								
				<p>
Spain is making dramatic progress towards eliminating hepatitis C among people l...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="CROI 2017: Higher than Expected HCV Prevalence Among HIV- Gay Men in Amsterdam PrEP Program::
	An unexpectedly high number of HIV-negative gay and bisexual men taking pre-exposure prophylaxis (PrEP) in Amsterdam were found to have hepatitis C virus (HCV) infection, suggesting HCV is being transmitted sexually between men with and without HIV, according to a presentation last month at...">
				  			<a href="/hiv-hep-coinfection/hiv-hcv-coinfection/6032-croi-2017-higher-than-expected-hcv-prevalence-among-hiv-gay-men-in-amsterdam-prep-program">
				  				CROI 2017: Higher than Expected HCV Prevalence Among HIV- Gay Men in Amsterdam PrEP Program				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="CROI 2017: DAA Therapy Cures HIV/HCV Coinfected People with Decompensated Cirrhosis or Transplants::
	HIV/HCV coinfected people with liver cirrhosis or liver failure, and those who received liver transplants, saw high rates of sustained virological response using interferon-free direct-acting antiviral (DAA) therapy for hepatitis C, according to 3 Spanish studies presented at the Conference on...">
				  			<a href="/hiv-hep-coinfection/hiv-hcv-coinfection/6022-croi-2017-daa-therapy-cures-hivhcv-coinfected-people-with-decompensated-cirrhosis-or-liver-transplants">
				  				CROI 2017: DAA Therapy Cures HIV/HCV Coinfected People with Decompensated Cirrhosis or Transplants				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="AASLD 2016: Sofosbuvir/ Ledipasvir Effective for HIV/HCV Coinfected People in Real-World Cohorts::
	The&amp;nbsp;sofosbuvir/ledipasvir&amp;nbsp;(Harvoni)&amp;nbsp;coformulation&amp;nbsp;used in real-world clinical practice produced good sustained&amp;nbsp;virological&amp;nbsp;response rates similar to those seen in clinical trials for HIV-positive people&amp;nbsp;coinfected&amp;nbsp;with hepatitis C, according to a pooled...">
				  			<a href="/hiv-hep-coinfection/hiv-hcv-coinfection/5936-aasld-2016-sofosbuvirledipasvir-effective-for-hivhcv-coinfected-people-in-real-world-cohorts">
				  				AASLD 2016: Sofosbuvir/ Ledipasvir Effective for HIV/HCV Coinfected People in Real-World Cohorts				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
														
								<div class="item article-column column3 " style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/hiv-hep-coinfection/551-hbv-hcv-coinfection" title="">
						<span>HBV/HCV Coinfection</span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/hiv-hep-coinfection/551-hbv-hcv-coinfection-hbv-hcv-coinfection/5227-easl-2015-hepatitis-b-and-c-coinfection-linked-to-worse-fibrosis-than-hepatitis-b-alone" title="EASL 2015: Hepatitis B and C Coinfection Linked to Worse Fibrosis than Hepatitis B Alone">EASL 2015: Hepatitis B and C Coinfection Linked to Worse Fibrosis than Hepatitis B Alone</a>
				</h4>
						
												
								
				<p>
People coinfected with both hepatitis B virus (HBV) and hepatitis C virus (HCV) ...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="DDW 2014: Outcomes in HBV/HCV Coinfected People Depend on Which Virus Dominates::
	Among HBV/HCV coinfected people, about half have dominant hepatitis B virus while half have dominant hepatitis C, and those with active HBV replication are at higher risk of liver-related complications and death, according to study findings presented at Digestive Disease Week this month in...">
				  			<a href="/hiv-hep-coinfection/551,633-hbv-hcv-coinfection-hbv-hcv-coinfection/4694-ddw-2014-outcomes-in-hbvhcv-coinfected-people-depend-on-which-virus-dominates">
				  				DDW 2014: Outcomes in HBV/HCV Coinfected People Depend on Which Virus Dominates				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="Adefovir plus Hepatitis C Therapy May Prevent HBV Reactivation in HBV-HCV Coinfected Patients::
	Due to the similar transmission routes, many people are dually infected with both hepatitis B virus (HBV) and hepatitis C virus (HCV). While the interaction between these 2 viruses is not fully understood, studies have shown that HBV seems to inhibit HCV replication and vice versa. As such,...">
				  			<a href="/hiv-hep-coinfection/551-hbv-hcv-coinfection-hbv-hcv-coinfection/1818-adefovir-plus-hepatitis-c-therapy-may-prevent-hbv-reactivation-in-hbv-hcv-coinfected-patients">
				  				Adefovir plus Hepatitis C Therapy May Prevent HBV Reactivation in HBV-HCV Coinfected Patients				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="ICAAC 2008: Another Study Confirms Hepatitis B Virus Suppresses Hepatitis C Virus Replication in HBV-HCV Coinfected Individuals::
	Due to overlapping transmission routes, many people are dually infected with both hepatitis B virus (HBV) and hepatitis C virus (HCV).

	In a poster presentation this week at the 48th International Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, DC, Italian...">
				  			<a href="/hiv-hep-coinfection/551,574-hbv-hcv-coinfection-hbv-hcv-coinfection/1382-another-study-confirms-hepatitis-b-virus-suppresses-hepatitis-c-virus-replication-in-hbv-hcv-coinfected-individuals">
				  				ICAAC 2008: Another Study Confirms Hepatitis B Virus Suppresses Hepatitis C Virus Replication in HBV-HCV Coinfected Individuals				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
														
								<div class="item article-column column4 col-last" style="width: 24.975%">
									
																		
								</div>
								
											    		
				    					    </div>
				
				
									
									
			
					<div class="ja-zinsec clearfix lime">
						
				    					    	<h2>
							<a href="/other-health-news" title="">
								<span>Other Health News</span>
							</a>
						</h2>
												
						<!-- User setting form -->
						<div class="ja-usersetting-wrap">
<div class="ja-usersetting" id="ja-usersetting-item-132-115">

	<a class="ja-usersetting-loadform" href="javascript:void(0)" onclick="return janewspro.showForm( $('ja-usersetting-item-132-115'))" id="ja-usersetting-loadform-132-115">
		<span>Setting</span>
	</a>
	
	<div class="ja-usersetting-options clearfix" style="overflow: hidden; height: 0; ">
		
		<form class="ja-usersetting-form" method="get" action="index.php" >
			<div class="ja-usersetting-form-inner clearfix">
			<input type="hidden" name="group" value="115" />
			<input type="hidden" name="moduleid" value="132" />
			
						<div class="ja-usersetting-row options-cat clearfix">

			<ul class="checkall">
				<li><input type="checkbox" id="checkall-132-115" name="checkall"  />
				<label for="checkall-132-115">Check all</label></li>
			</ul>
		
			<ul class="catselect">
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="146" id="ja-category-146" name="categories[]" />
					<label for="ja-category-146">Tuberculosis (TB)</label>
				</li>
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="471" id="ja-category-471" name="categories[]" />
					<label for="ja-category-471">Human Papillomavirus (HPV)</label>
				</li>
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="203" id="ja-category-203" name="categories[]" />
					<label for="ja-category-203">Other STDs</label>
				</li>
								<li>
					<input type="checkbox" checked="checked" class="checkbox" value="557" id="ja-category-557" name="categories[]" />
					<label for="ja-category-557">Influenza</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="603" id="ja-category-603" name="categories[]" />
					<label for="ja-category-603">West Nile Virus</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="516" id="ja-category-516" name="categories[]" />
					<label for="ja-category-516">Antibiotic Resistance</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="521" id="ja-category-521" name="categories[]" />
					<label for="ja-category-521">XMRV & Other Retroviruses</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="587" id="ja-category-587" name="categories[]" />
					<label for="ja-category-587">Oncology</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="563" id="ja-category-563" name="categories[]" />
					<label for="ja-category-563">Health Care & Insurance Reform</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="561" id="ja-category-561" name="categories[]" />
					<label for="ja-category-561">LGBT Health </label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="585" id="ja-category-585" name="categories[]" />
					<label for="ja-category-585">Miscellaneous Health News</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="604" id="ja-category-604" name="categories[]" />
					<label for="ja-category-604">Emerging Diseases</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="623" id="ja-category-623" name="categories[]" />
					<label for="ja-category-623">Other Liver Disease</label>
				</li>
								<li>
					<input type="checkbox"  class="checkbox" value="655" id="ja-category-655" name="categories[]" />
					<label for="ja-category-655">Drug Use and Harm Reduction</label>
				</li>
							</ul>
			</div>
			
			<div class="ja-usersetting-row options-content clearfix">			
				<ul>
					<li>
						<label for="introitems132-115" class="jahasTip" title="Number of intro items will be displayed on frontpage">Intro Items</label>
						<input type="text" name="introitems" id="introitems132-115" value="1" class="inputbox" />
					</li>
					<li>
						<label for="linkitems132-115" class="jahasTip" title="Number of link items will be displayed on frontpage">Link Items</label>
						<input type="text" name="linkitems" id="linkitems132-115" value="3" class="inputbox" />
					</li>
				</ul>
			</div>
			
			<div class="ja-usersetting-row options-img clearfix">
				<ul>
					<li>
						<label class="jahasTip" title="Show/Hide image of article on frontpage">Show Image</label>
					</li>
					<li>
						<input type="radio" name="showimage" id="showimage132-1151" value="1"  class="radio" />
						<label for="showimage132-1151">Show</label>
					</li>
					<li>
						<input type="radio" name="showimage" id="showimage132-1150" value="0" checked="checked" class="radio" />
						<label for="showimage132-1150">Hide</label>
					</li>
				</ul>
			</div>
			
			<div class="ja-usersetting-actions clearfix">
				<input type="button" class="button ja-submit" name="ja-submit" value="Save" />
				<input type="button" class="button ja-cancel" name="ja-cancel" value="Cancel" />
			</div>
		</div>
		</form>
	</div>
</div>
</div>						<!-- End -->
									
						 <!-- Group by sub category -->
				    		
				    									
								<div class="item article-column column1 col-first" style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/other-health-news/other-health-news-topics/tuberculosis" title="">
						<span>Tuberculosis (TB)</span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/other-health-news/other-health-news-topics/tuberculosis/6023-croi-2017-prednisone-reduces-risk-of-developing-tb-iris-after-starting-antiretroviral-treatment" title="CROI 2017: Prednisone Reduces Risk of Developing TB-IRIS after Starting Antiretroviral Treatment">CROI 2017: Prednisone Reduces Risk of Developing TB-IRIS after Starting Antiretroviral Treatment</a>
				</h4>
						
												
								
				<p>
Prednisone reduces the risk of immune restoration inflammatory syndrome (IRIS) i...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="CROI 2017: Isoniazid Preventive Therapy for TB Reduces Risk of Death for People Living with HIV::
	A 6-month course of isoniazid preventive treatment (IPT) for at the beginning of the Temprano trial in Ivory Coast reduced the risk of death by 37% over a mean follow-up period of 4.5 years, Anani Badje reported at the&amp;nbsp;Conference on Retroviruses and Opportunistic Infections this month in...">
				  			<a href="/other-health-news/other-health-news-topics/tuberculosis/6012-croi-2017-isoniazid-preventive-therapy-for-tb-reduces-risk-of-death-for-people-living-with-hiv">
				  				CROI 2017: Isoniazid Preventive Therapy for TB Reduces Risk of Death for People Living with HIV				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="CROI 2017: Triple Tuberculosis Regimen Beats XDR-TB in First Trial::
	A regimen of three oral drugs given for 6 months was enough to clear extensively drug-resistant tuberculosis (XDR-TB) in 29 of the first 31 people to have completed the treatment course, Francesca Conradie of Sizwe Tropical Disease Hospital in Johannesburg reported at the&amp;nbsp;2017 Conference on...">
				  			<a href="/other-health-news/other-health-news-topics/tuberculosis/5997-croi-2017-triple-tuberculosis-regimen-beats-xdr-tb-in-first-trial">
				  				CROI 2017: Triple Tuberculosis Regimen Beats XDR-TB in First Trial				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="AIDS 2016: New WHO Algorithm Aims to Prevent TB Deaths in People with Advanced HIV::
	The World Health Organization (WHO) has released a new diagnostic algorithm to reduce the likelihood of seriously ill people with HIV dying of undiagnosed and untreated tuberculosis (TB). The algorithm was presented at a scientific workshop at the 21st International AIDS Conference last month in...">
				  			<a href="/other-health-news/other-health-news-topics/tuberculosis/5831-aids-2016-new-who-algorithm-aims-to-prevent-tb-deaths-in-people-with-advanced-hiv">
				  				AIDS 2016: New WHO Algorithm Aims to Prevent TB Deaths in People with Advanced HIV				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
														
								<div class="item article-column column2 " style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/other-health-news/other-health-news-topics/hpv" title="">
						<span>Human Papillomavirus (HPV)</span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/other-health-news/other-health-news-topics/hpv/6174-eacs-2017-european-aids-clinical-society-strengthens-hpv-vaccination-advice" title="EACS 2017: European AIDS Clinical Society Strengthens HPV Vaccination Advice">EACS 2017: European AIDS Clinical Society Strengthens HPV Vaccination Advice</a>
				</h4>
						
												
								
				<p>
The European AIDS Clinical Society (EACS) has recommended human papillomavirus (...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="PAS 2017: Vaccine Reduces Human Papillomavirus Prevalence Among Young Women::
	The prevalence of human papillomavirus (HPV) types included in the most widely used vaccine has decreased among adolescent and young women in the U.S., with &amp;quot;herd immunity&amp;quot; extending to those who were not vaccinated themselves, according to study results presented at the Pediatric...">
				  			<a href="/hpv/hpv-vaccines/6066-pas-2017-vaccine-reduces-human-papillomavirus-prevalence-among-young-women">
				  				PAS 2017: Vaccine Reduces Human Papillomavirus Prevalence Among Young Women				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="Young Adolescents Need Only 2 Doses of Human Papillomavirus Vaccine, CDC Says::
	Adolescents age 11-14 years can receive 2 doses of the human papillomavirus (HPV) vaccine to prevent cancers caused by&amp;nbsp;HPV, rather than the 3 doses previously recommended, according to the U.S. Centers for Disease Control and Prevention (CDC). This change is supported by a systematic review...">
				  			<a href="/hpv/hpv-vaccines/5918-young-adolescents-need-only-2-doses-of-human-papillomavirus-vaccine-cdc-says">
				  				Young Adolescents Need Only 2 Doses of Human Papillomavirus Vaccine, CDC Says				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="Gardasil HPV Vaccine Reduces Occurrence of Genital Warts and Cervical Dysplasia::
	&amp;nbsp;

	Countries that widely use a quadrivalent human papillomavirus (HPV) vaccine have seen up to a 90% reduction in HPV infections and decreases in the incidence of genital warts and cervical cell abnormalities that can lead to cancer, according to an analysis of nearly 60 studies from 9...">
				  			<a href="/other-health-news/other-health-news-topics/hpv/5763-gardasil-hpv-vaccine-reduces-occurrence-of-genital-warts-and-cervical-dysplasia">
				  				Gardasil HPV Vaccine Reduces Occurrence of Genital Warts and Cervical Dysplasia				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
														
								<div class="item article-column column3 " style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/other-health-news/other-health-news-topics/other-stds" title="">
						<span>Other STDs</span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/other-health-news/other-health-news-topics/other-stds/477,667-gonorrhea-gonorrhea/5908-idweek-rapid-emergence-of-drug-resistant-gonorrhea-seen-in-ohio" title="IDWeek 2016: Rapid Emergence of Drug-Resistant Gonorrhea Seen in Ohio">IDWeek 2016: Rapid Emergence of Drug-Resistant Gonorrhea Seen in Ohio</a>
				</h4>
						
												
								
				<p>
Routine surveillance in southern Ohio has detected a steep increase in gonorrhea...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="Sexually Transmitted Disease Rates Hit New Highs, CDC Report Says::
	Cases of chlamydia, gonorrhea, and syphilis are at their highest level ever -- exceeding last year&amp;#39;s record levels -- even as STD prevention, testing, and treatment services have eroded, according to the latest Sexually Transmitted Disease Surveillance report, released this week by the...">
				  			<a href="/other-health-news/other-health-news-topics/other-stds/5883-sexually-transmitted-disease-rates-hit-new-highs-cdc-report-says">
				  				Sexually Transmitted Disease Rates Hit New Highs, CDC Report Says				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="STD 2016: Syphilis Rates Are Rising Among Gay Men, CDC Data Show::
	New state-level data reveal that syphilis cases continue to rise among gay and bisexual men, with men in the south having the highest rates, according to a presentation at the 2016 STD Prevention Conference last week in Atlanta. A related study found that half of gay and bisexual men in 20...">
				  			<a href="/other-health-news/other-health-news-topics/other-stds/480,671-syphilis-syphilis/5865-std-2016-syphilis-rates-are-rising-among-gay-men-cdc-data-show">
				  				STD 2016: Syphilis Rates Are Rising Among Gay Men, CDC Data Show				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="STD 2016: Growing Threat of Antibiotic-Resistant Gonorrhea in the U.S. and Worldwide::
	Public health officials in Hawaii have identified the first cluster of gonorrhea cases with reduced susceptibility to both drugs in the current recommended regimen, according to a report at the 2016 STD Prevention Conference taking place this week in Atlanta. While all 7 patients were...">
				  			<a href="/other-health-news/other-health-news-topics/other-stds/477,671-gonorrhea-gonorrhea/5860-growing-threat-of-antibiotic-resistant-gonorrhea-in-the-us-and-worldwide">
				  				STD 2016: Growing Threat of Antibiotic-Resistant Gonorrhea in the U.S. and Worldwide				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
														
								<div class="item article-column column4 col-last" style="width: 24.975%">
									
									<div class="ja-box column ja-zintheme ja-box-first">
	<div class="ja-box-inner clearfix">
							
			<div class="ja-zincat clearfix">
				<h3>
					<a href="/other-health-news/other-health-news-topics/influenza-blog" title="">
						<span>Influenza</span>
					</a>
				</h3>
			</div>
				
					
			<div class="ja-zincontent clearfix">
				<h4 class="ja-zintitle">
					<a href="/other-health-news/other-health-news-topics/influenza-blog/4826-icaac-2014-single-dose-of-flu-drug-peramavir-looks-safe-and-effective" title="ICAAC 2014: Single Dose of Flu Drug Peramavir Looks Safe and Effective">ICAAC 2014: Single Dose of Flu Drug Peramavir Looks Safe and Effective</a>
				</h4>
						
												
								
				<p>
A single dose of the investigational neuraminidase inhibitorperamavir (Rapivab) ...
</p>
							</div>			
								
				<div class="ja-zinlinks clearfix">
			<strong>MORE:</strong>			
			<ul class="jazin-links">
					
										<li>
						<span  class="editlinktip jahasTip" title="Most States Have Widespread Flu Outbreaks, Young and Middle-aged at Greatest Risk::
	All regions of the U.S. are now experiencing influenza outbreaks, predominantly with the H1N1 &amp;quot;swine flu&amp;quot; strain, according to the Centers for Disease Control and Prevention (CDC). In contrast to some prior flu epidemics, young and middle-aged adults -- rather than young children and...">
				  			<a href="/other-health-news/other-health-news-topics/influenza-blog/4486-most-states-have-widespread-flu-outbreaks-young-and-middle-aged-at-greatest-risk">
				  				Most States Have Widespread Flu Outbreaks, Young and Middle-aged at Greatest Risk				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="2012-2013 Could Be Bad Flu Season, Not Too Late to Get Vaccine, CDC Advises::
	Significant increases in influenza activity in the U.S. during the past 2 weeks indicate that this year&amp;#39;s flu season has come early, and it could be a bad one, according to the Centers for Disease Control and Prevention (CDC). December 2-8 is National Influenza Vaccination Week, and it&amp;#39;s...">
				  			<a href="/other-health-news/other-health-news-topics/influenza-blog/3902-2012-2013-could-be-bad-flu-season-not-too-late-to-get-vaccine-cdc-advises">
				  				2012-2013 Could Be Bad Flu Season, Not Too Late to Get Vaccine, CDC Advises				  			</a>
			  			</span>
		  			</li>
					
										<li>
						<span  class="editlinktip jahasTip" title="West Nile Virus Outbreak May Be Largest Ever in U.S., Says CDC::&lt;p&gt;
	Based on the number of cases so far this year, 2012 looks like it will have one of the worst outbreaks of mosquito-borne West Nile virus in the U.S. to date, Centers for Disease Control and Prevention (CDC) announced during a media telebriefing this week.&lt;/p&gt;">
				  			<a href="/other-health-news/other-health-news-topics/influenza-blog/3751-west-nile-virus-outbreak-may-be-largest-ever-in-us-says-cdc">
				  				West Nile Virus Outbreak May Be Largest Ever in U.S., Says CDC				  			</a>
			  			</span>
		  			</li>
							</ul>
		</div>
				
	</div>
</div>
									
								</div>
								
											    		
				    					    </div>
				
				
							</div>
			
				
		</div>
</div>
<script type="text/javascript">
	var janewspro = null;
	var jasiteurl = 'http://www.hivandhepatitis.com/';
	window.addEvent('load', function(){
		janewspro = new JANEWSPRO(); 
		janewspro._bindingAndprocessingEventForm($('ja-zinwrap-132'));
		document.getElements('.jahasTip').each(function(el) {
		var title = el.get('title');
		if (title) {
		 var parts = title.split('::', 2);
		 el.store('tip:title', parts[0]);
		 el.store('tip:text', parts[1]);
		}
	   });
	   var JTooltips = new Tips(document.getElements('.jahasTip'), { maxTitleChars: 50, fixed: false});
		//new Tips($('ja-zinwrap-132').getElements('.jahasTip'), { maxTitleChars: 50, fixed: false, className: 'tool-tip janews-tool'});
	})
</script>	
</div>

</div>		 
		
						</div>
				
				<div id="ja-contentwrap" class="clearfix ">
					<div id="ja-content" class="column" style="width:100%">
						<div id="ja-current-content" class="column" style="width:100%">
														
							
													</div>
						
											</div>

										
				</div>

							</div>
			</div>
			<!-- //CONTENT -->
						
		</div>
				<!-- RIGHT COLUMN--> 
		<div id="ja-right" class="column sidebar" style="width:34%">

			
									<div id="ja-right-mass-bottom" class="ja-mass ja-mass-bottom clearfix">
					<div class="ja-moduletable moduletable  clearfix" id="Mod177">
						<h3><span>CONFERENCE COVERAGE</span></h3>
				<div class="ja-box-ct clearfix">
		<div class="custom">
	<table border="0" cellpadding="5" cellspacing="5">
	<tbody>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/aasld-logo-new-crop-sq50.jpg" /></td>
			<td style="width: 408px;">
				<a href="http://www.hivandhepatitis.com/hepatitis-b/hepatitis-b-topics/hbv-treatment/6161-coverage-of-the-2017-aasld-liver-meeting2"><b><font face="Arial, Helvetica, sans-serif" size="-1">The Liver Meeting (AASLD&nbsp;2017)</font></b></a><b><font face="Verdana, Arial, Helvetica, sans-serif" size="-1">&nbsp;</font></b><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">October 20-24, 2017, Washington, DC</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/eacs2017-stripes-sq50.jpg" /></td>
			<td style="width: 408px;">
				<p>
					<a href="http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/6184-coverage-of-the-16th-european-aids-conference"><b style="margin: 0px; padding: 0px; border: 0px; outline: 0px; font-size: 12px; background: transparent;"><font face="Arial, Helvetica, sans-serif" style="margin: 0px; padding: 0px; border: 0px; outline: 0px; background: transparent;"><span style="border-style: initial; border-color: initial; border-image: initial; outline-color: initial; outline-style: initial; font-size: 12px; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">6th European AIDS Conference (EACS 2017)</span></font></b></a><b style="margin: 0px; padding: 0px; border: 0px; outline: 0px; font-size: 12px; background: transparent;"><font face="Arial, Helvetica, sans-serif" style="margin: 0px; padding: 0px; border: 0px; outline: 0px; background: transparent;"></font></b><br style="color: rgb(51, 51, 51); font-size: 12px;" />
					<span style="margin: 0px; padding: 0px; border: 0px; outline: 0px; font-size: 12px; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" style="margin: 0px; padding: 0px; border: 0px; outline: 0px; background: transparent;">October 20-27, 2017, Milan</font></span></p>
			</td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/ias2017-logo-sq50.jpg" /></td>
			<td style="width: 408px;">
				<a href="http://hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/6123-coverage-of-the-2017-ias-conference-on-hiv-science"><b><font face="Arial, Helvetica, sans-serif" size="-1">9th IAS Conference on HIV Science (IAS 2017)</font></b></a><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">July 23-26, 2017, Paris</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/hr17-logo-sq50.jpg" /></td>
			<td style="width: 408px;">
				<b><a href="http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/6079-coverage-of-the-2017-harm-reduction-international-conference"><font face="Arial, Helvetica, sans-serif" size="-1">2017 Harm Reduction International Conference</font></a><font face="Verdana, Arial, Helvetica, sans-serif" size="-1">&nbsp;</font></b><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">May 14-17, 2017, Montreal</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/pas2017-sq50.jpg" /></td>
			<td style="width: 408px;">
				<a href="http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/6074-coverage-of-the-2017-pediatric-academic-societies-meeting-listing"><b><font face="Arial, Helvetica, sans-serif" size="-1">2017 Pediatric Academic Societies Meeting</font></b></a><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">May 6-9, 2017, San Francisco</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/easl2017-sq50.jpg" /></td>
			<td style="width: 408px;">
				<a href="http://www.hivandhepatitis.com/hepatitis-b/6080-coverage-of-the-2017-easl-international-liver-conference"><b><font face="Arial, Helvetica, sans-serif" size="-1">2017 EASL International Liver Congress</font></b></a><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">April 19-23, 2017, Amsterdam</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/croi2017-program-pic-crop-sq50.jpg" /></td>
			<td style="width: 408px;">
				<b><a href="http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/6042-coverage-of-the-2017-conference-on-retroviruses-and-opportunistic-infections"><font face="Arial, Helvetica, sans-serif" size="-1">2017 Conference on&nbsp;Retroviruses&nbsp;and Opportunistic Infections (CROI&nbsp;2017)</font></a><font face="Verdana, Arial, Helvetica, sans-serif" size="-1">&nbsp;</font></b><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">February 13-16, 2017, Seattle</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/aasld-logo-sq50.jpg" /></td>
			<td style="width: 408px;">
				<a href="http://www.hivandhepatitis.com/hepatitis-b/hepatitis-b-topics/hbv-treatment/5932-coverage-of-the-2016-aasld-liver-meeting1"><b><font face="Arial, Helvetica, sans-serif" size="-1">The Liver Meeting (AASLD&nbsp;2016)</font></b></a><b><font face="Verdana, Arial, Helvetica, sans-serif" size="-1">&nbsp;</font></b><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">November 11-15, 2016, Boston</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/idweek2014-text-sq-50.jpg" /></td>
			<td style="width: 408px;">
				<a href="http://hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/5910-coverage-of-idweek-2016"><font face="Arial, Helvetica, sans-serif" size="2"><b>IDWeek&nbsp;2016</b></font></a><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">October 26-30, 2016, New Orleans</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/hivdrugtherapy2016-sq50.jpg" /></td>
			<td style="width: 408px;">
				<b><a href="http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/5911-coverage-of-hiv-drug-therapy-2016"><font face="Arial, Helvetica, sans-serif" size="-1">HIV Drug Therapy 2016</font></a><font face="Verdana, Arial, Helvetica, sans-serif" size="-1">&nbsp;</font></b><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">October 23-26, 2016, Glasgow</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/hivr4p-logo-sq50.jpg" /></td>
			<td style="width: 408px;">
				<a href="http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-prevention/5887-coverage-of-hiv-research-for-prevention-hiv-r4p-2016"><font face="Arial, Helvetica, sans-serif" size="2"><b>HIV Research for Prevention (HIVR4P 2016)</b></font></a><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">October 17-21, 2016, Chicago</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img align="right" alt="alt" src="/images/conf-logos-banners/inhsu2016-arch-text1-sq50.jpg" /></td>
			<td style="width: 408px;">
				<a href="http://www.hivandhepatitis.com/hepatitis-c/hepatitis-c-topics/hcv-populations/509-hcv-injection-drug-users-hcv-injection-drug-users/5871-coverage-of-5th-international-symposium-on-hepatitis-care-in-substance-users-inhsu-2015"><font face="Arial, Helvetica, sans-serif" size="2"><b>5th&nbsp;International Symposium on Hepatitis Care in Substance Users (INHSU&nbsp;2016)</b></font></a><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">Sept 7-9, 2016,&nbsp;Oslo</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/aids2016-logo1-sq50.jpg" /></td>
			<td style="width: 408px;">
				<b><a href="http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/5802-coverage-of-the-2016-international-aids-conference"><font face="Arial, Helvetica, sans-serif" size="-1">21st International AIDS Conference (AIDS 2016)</font></a><font face="Verdana, Arial, Helvetica, sans-serif" size="-1">&nbsp;</font></b><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">July 18-22, 2016, Durban</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/asm2016-logo2-sq50.jpg" /></td>
			<td style="width: 408px;">
				<a href="http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/5765-coverage-of-asm-microbe-2016-including-icaac-2016"><font face="Arial, Helvetica, sans-serif" size="2"><b>ASM Microbe 2016/ICAAC 2016</b></font></a><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">June 16-20, 2016, Boston</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/ilc2016-year-sq50.jpg" /></td>
			<td style="width: 408px;">
				<a href="http://hivandhepatitis.com/hepatitis-c/hepatitis-c-topics/hcv-treatment/5700-coverage-of-the-2016-easl-international-liver-congress-d1"><b><font face="Arial, Helvetica, sans-serif" size="-1">2016 EASL International Liver Congress</font></b></a><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">April 13-17, 2016, Barcelona</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/croi2016-logo-crop-sq50.jpg" /></td>
			<td style="width: 408px;">
				<b><font face="Arial, Helvetica, sans-serif" size="-1"><a href="http://hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/5617-coverage-of-the-2016-conference-on-retroviruses-and-opportunistic-infections">2016 Conference on&nbsp;Retroviruses&nbsp;and Opportunistic Infections (CROI&nbsp;2016)</a></font><a href="/croi-2013"><font face="Verdana, Arial, Helvetica, sans-serif" size="-1">&nbsp;</font></a></b><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">February 22-25, 2016, Boston</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/nhpc2015-logo-sq50.jpg" /></td>
			<td style="width: 408px;">
				<b><a href="http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-prevention/5525-coverage-of-the-2015-national-hiv-prevention"><font face="Arial, Helvetica, sans-serif" size="-1">2015 National HIV Prevention Conference (NHPC 2015)</font></a><font face="Verdana, Arial, Helvetica, sans-serif" size="-1">&nbsp;</font></b><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">December 6-9, 2015, Atlanta</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/tb-unionworld-2015-sq2-50.jpg" /></td>
			<td style="width: 408px;">
				<b><a href="http://207.56.172.200/hivandhepatitis/wclh2015.html"><font face="Arial, Helvetica, sans-serif" size="-1">46th Union World Conference on Lung Health</font></a><font face="Verdana, Arial, Helvetica, sans-serif" size="-1">&nbsp;</font></b><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">December 2-6, 2015, Cape Town</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/aasld2015-logo-app-text-sq1-50.jpg" /></td>
			<td style="width: 408px;">
				<a href="http://www.hivandhepatitis.com/hepatitis-b/hepatitis-b-topics/hbv-treatment/5495-coverage-of-the-2015-aasld-liver-meeting1"><b><font face="Arial, Helvetica, sans-serif" size="-1">The Liver Meeting (AASLD&nbsp;2015)</font></b></a><b><font face="Verdana, Arial, Helvetica, sans-serif" size="-1">&nbsp;</font></b><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">November 13-17, 2015, San Francisco</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/eacs2015-logo-sq50.jpg" /></td>
			<td style="width: 408px;">
				<a href="http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/5454-coverage-of-the-15th-european-aids-conference"><b><font face="Arial, Helvetica, sans-serif" size="-1">15th&nbsp;European AIDS Conference (EACS&nbsp;2015)</font><font face="Verdana, Arial, Helvetica, sans-serif" size="-1">&nbsp;</font></b></a><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">October 21-24, 2015, Barcelona</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/harmreduction2015-logo-sq50.jpg" /></td>
			<td style="width: 408px;">
				<a href="http://www.hivandhepatitis.com/hepatitis-c/hepatitis-c-topics/hcv-prevention/188,650-hcv-injection-drug-use-hcv-injection-drug-use/5453-coverage-of-the-2015-international-harm-reduction-conference"><font face="Arial, Helvetica, sans-serif" size="2"><b>24th&nbsp;International Harm Reduction Conference (IHRC&nbsp;2015)</b></font></a><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">October 18-21, 2015,&nbsp;Kuala Lumpur</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/idweek2015-logo-sq50.jpg" /></td>
			<td style="width: 408px;">
				<a href="http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/5404-coverage-of-idweek-2015"><font face="Arial, Helvetica, sans-serif" size="2"><b>IDWeek 2015</b></font></a><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">October 7-11, 2015, San Diego</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/inhsu2015-logo-sq2-50.jpg" /></td>
			<td style="width: 408px;">
				<a href="http://www.hivandhepatitis.com/hepatitis-c/hepatitis-c-topics/hcv-populations/509-hcv-injection-drug-users-hcv-injection-drug-users/5422-coverage-of-4th-international-symposium-on-health-care-in-substance-users-inhsu-2015"><font face="Arial, Helvetica, sans-serif" size="2"><b>4th&nbsp;International Symposium on Hepatitis Care in Substance Users (INHSU&nbsp;2015)</b></font></a><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">October 7-9, 2015,&nbsp;Sydney</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/icaac-icc-2015-sq50.jpg" /></td>
			<td style="width: 408px;">
				<b><font face="Arial, Helvetica, sans-serif" size="-1"><a href="http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/5403-coverage-of-2015-interscience-conference-on-antimicrobial-agents-and-chemotherapy">55th&nbsp;Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2015)</a></font></b><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">September 17-21, 2015, San Diego</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img align="right" alt="alt" src="/images/conf-logos-banners/ias2015-sm2-sq50.jpg" /></td>
			<td style="width: 408px;">
				<a href="http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/5272-coverage-of-the-2015-international-aids-society-conference"><b><font face="Arial, Helvetica, sans-serif" size="-1">8th International AIDS Society Conference on HIV Pathogenesis, Treatment &amp; Prevention (IAS&nbsp;2015)</font><font face="Verdana, Arial, Helvetica, sans-serif" size="-1">&nbsp;</font></b></a><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">July 19-22, 2015, Vancouver</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/ddw2015-logo-sq50.jpg" /></td>
			<td style="width: 408px;">
				<a href="http://207.56.172.200/hivandhepatitis/ddw2015.html"><b><font face="Arial, Helvetica, sans-serif" size="-1">Digestive Disease Week 2015</font></b></a><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">May 16-19, 2015, Washington, DC</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img align="left" alt="alt" src="/images/conf-logos-banners/easl2015-logo-sq50.jpg" /></td>
			<td style="width: 408px;">
				<b><a href="http://www.hivandhepatitis.com/hepatitis-c/hepatitis-c-topics/hcv-treatment/5204-coverage-of-the-2015-easl-international-liver-congress-d1"><font face="Arial, Helvetica, sans-serif" size="-1">50th&nbsp;International Liver Congress (EASL&nbsp;2015)</font></a><font face="Verdana, Arial, Helvetica, sans-serif" size="-1">&nbsp;</font></b><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">April 22-26, 2015, Vienna</font></span></td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img alt="alt" src="/images/conf-logos-banners/bhivalogo2-dark-sq50.jpg" /></td>
			<td style="width: 408px;">
				<p>
					<b><a href="http:// http://207.56.172.200/hivandhepatitis/bhiva2015.html"><font face="Arial, Helvetica, sans-serif" size="-1">21st Annual Meeting of the British HIV Association (BHIVA)</font></a><font face="Verdana, Arial, Helvetica, sans-serif" size="-1">&nbsp;</font></b><br />
					<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">April 21-24, 2015, Brighton</font></span></p>
			</td>
		</tr>
		<tr>
			<td style="width: 50px;">
				<img align="left" alt="alt" src="/images/conf-logos-banners/croi2015-program2-sq-50.jpg" /></td>
			<td style="width: 408px;">
				<b><font face="Arial, Helvetica, sans-serif" size="-1"><a href="http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/5084-coverage-of-the-2015-conference-on-retroviruses-and-opportunistic-infections-1">2015 Conference on&nbsp;Retroviruses&nbsp;and Opportunistic Infections (CROI&nbsp;2015)</a></font><a href="/croi-2013"><font face="Verdana, Arial, Helvetica, sans-serif" size="-1">&nbsp;</font></a></b><br />
				<span style="color: rgb(105, 105, 105);"><font face="Arial, Helvetica, sans-serif" size="-1">February 23-26, 2015, Seattle</font></span></td>
		</tr>
	</tbody>
</table>
<p>
	<span style="font-size:16px;"><strong><a href="/home1706522085/content/past-conferences-menu">Previous Conferences...</a></strong></span></p>
</div>		</div>
    </div>
				</div>
					</div>
		<!-- //RIGHT COLUMN--> 
					 
			</div>
		 
		
				
					</div>
		
			
					</div>
		<!-- //MAIN CONTAINER -->

					<div id="ja-footer" class="wrap ">		
				
			
					<div class="main">
		
				
		 
			<div class="main-inner1 clearfix">
		<!--	<div id="ja-footlogo" >
		<a href="/index.php" title="www.hivandhepatitis.com"><span>www.hivandhepatitis.com</span></a>
	</div>-->

		<div class="ja-footnav">
		
<ul class="menu">
<li id="item-464"><a href="/homepage" >Home</a></li><li id="item-444"><a href="/home1706522085/about-us/overview" >About</a></li><li id="item-207"><a href="/contact-us-menu" >Contact Us</a></li></ul>
	</div>
		
	<div class="ja-copyright">
		<small>Copyright &#169; 2020 www.hivandhepatitis.com. All Rights Reserved. Designed by <a href="http://www.joomlart.com/" title="Visit Joomlart.com!">JoomlArt.com</a>.</small>
<small><a href="http://www.joomla.org">Joomla!</a> is Free Software released under the <a href="http://www.gnu.org/licenses/gpl-2.0.html">GNU General Public License.</a></small>
<div class="custom">
	<p>
	<img alt="Bread and Roses Web Design" src="/images/icons/logo-tiny.jpg" style="width: 30px; height: 35px; margin-left: 10px; margin-right: 10px;" />Web Design and Development by <a href="http://www.breadandrosesweb.com/">Bread and Roses Web Design</a></p>
</div>
	</div>		 
			</div>
		 
		
				
					</div>
		
			
				</div>		
				
</div>



</body>

</html>